Notices of Compliance, 2026
1,769 notices issued in 2026, newest first.
| Date | Products | Company | Submission |
|---|---|---|---|
| October 9, 2026 | JAMP IBUPROFEN | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| October 9, 2026 | CARVYKTI | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 9, 2026 | VIGAMOX | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 9, 2026 | RAMIPRIL CAPSULES | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 9, 2026 | NEURAXPHARM-MODAFINIL | Neuraxpharm Pharmaceuticals, S.L. | New Drug Submission (NDS) · Labelling Only |
| October 9, 2026 | CYKLOKAPRON | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| October 9, 2026 | XOLAIR | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 9, 2026 | VFEND | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| October 9, 2026 | LEUCOVORIN CALCIUM INJECTION | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| October 9, 2026 | DOXYCIN CAPSULES; DOXYCIN TABLETS | Laboratoire Riva Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 9, 2026 | RIVA SITAGLIPTIN | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 9, 2026 | JAMP ELTROMBOPAG | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| October 9, 2026 | NALOXONE HYDROCHLORIDE INJECTION | Juno Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 9, 2026 | PEGYLATED LIPOSOMAL DOXORUBICIN HYDROCHLORIDE FOR INJECTION | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 9, 2026 | PMS-LOXAPINE | Pharmascience Inc. | New Drug Submission (NDS) · Admin |
| October 9, 2026 | LABETALOL HYDROCHLORIDE INJECTION | Juno Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 8, 2026 | AURO-MYCOPHENOLIC ACID | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 8, 2026 | GLN-METFORMIN XR | Glenmark Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 8, 2026 | SANDOZ CANDESARTAN PLUS | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 8, 2026 | MINT-LEVODOPA/BENSERAZIDE | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| October 8, 2026 | OCZYESA XR | Camurus Ab | New Drug Submission (NDS) · Other |
| October 8, 2026 | YORVIPATH | Pendopharm Division Of Pharmascience Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 8, 2026 | ACTONEL; ACTONEL DR | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| October 8, 2026 | JASCAYD | Boehringer Ingelheim (Canada) Ltd. | New Drug Submission (NDS) · New Active Substance (NAS) |
| October 8, 2026 | SPC-ROSUVASTATIN | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 8, 2026 | MYCOPHENOLATE MOFETIL | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 7, 2026 | SEPHIENCE | Ptc Therapeutics International Limited | Supplement to a New Drug Submission (SNDS) · Other |
| October 7, 2026 | SANDOZ DORZOLAMIDE/TIMOLOL | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 7, 2026 | TEVA-SALBUTAMOL HFA | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| October 7, 2026 | TOBI PODHALER | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| October 7, 2026 | DUAKLIR GENUAIR | Azurity Pharmaceuticals Ireland Limited | New Drug Submission (NDS) · Admin |
| October 7, 2026 | PRO-METOPROLOL; PRO-METOPROLOL-L | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Admin |
| October 7, 2026 | CAPRELSA | Esteve Pharmaceuticals S.A. | New Drug Submission (NDS) · Admin |
| October 6, 2026 | BILASTINE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 6, 2026 | TYSABRI | Biogen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 6, 2026 | CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE; CISATRACURIUM SINGLE DOSE | Juno Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 6, 2026 | XYNTHA SOLOFUSE | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| October 6, 2026 | DUPIXENT | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 6, 2026 | ANDEMBRY | Csl Behring Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 6, 2026 | PMS-DICLOFENAC | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 6, 2026 | JAMP ELAGOLIX | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| October 5, 2026 | DIASTAT | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 5, 2026 | SANDOZ METFORMIN FC | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 5, 2026 | PRO-NAPROXEN; PRO-NAPROXEN EC | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Admin |
| October 5, 2026 | NRA-DULOXETINE | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 5, 2026 | NB-DULOXETINE | NB Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 2, 2026 | FREHEMGO | Novo Nordisk Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| October 2, 2026 | DARZALEX SC | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 2, 2026 | OLMESARTAN MEDOXOMIL / HYDROCHLOROTHIAZIDE | Jubilant Generics Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 2, 2026 | VOXZOGO | Biomarin International Limited | Supplement to a New Drug Submission (SNDS) · Other |
| October 2, 2026 | WEGOVY | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 2, 2026 | AURO-ATOVAQUONE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 2, 2026 | APO-MYCOPHENOLIC ACID | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 2, 2026 | EZETIMIBE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 2, 2026 | ALLEGRA 12 HOUR; ALLEGRA 24 HOUR; ALLEGRA HIVES | Opella Canada Inc. | New Drug Submission (NDS) · Admin |
| October 1, 2026 | ZEJULA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 1, 2026 | DONEPEZIL HYDROCHLORIDE | Jubilant Generics Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 1, 2026 | ACTIFEMME LD | Novast Laboratories Ltd. | Abbreviated New Drug Submission (ANDS) · Other |
| October 1, 2026 | TEVA-RISEDRONATE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 1, 2026 | AURO-HYDROXYCHLOROQUINE | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 1, 2026 | PMS-ROSUVASTATIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 1, 2026 | JAMP-MYCOPHENOLATE CAPSULES | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 1, 2026 | PLIAGLIS | Sciences de la Peau CRESCITA Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 29, 2026 | PARNATE | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 29, 2026 | PMS-SACUBITRIL-VALSARTAN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 29, 2026 | RIVA-ROSUVASTATIN | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 29, 2026 | PMS-METHADONE TABLETS | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 29, 2026 | TLANDO | Verity Pharmaceuticals Inc | New Drug Submission (NDS) · Other |
| September 29, 2026 | CAPVAXIVE | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 29, 2026 | MYCOPHENOLATE MOFETIL FOR INJECTION USP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 29, 2026 | IQIRVO | Ipsen Biopharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 29, 2026 | BIO-ANASTROZOLE | Biomed Pharma | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 29, 2026 | BIO-PRAVASTATIN | Biomed Pharma | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 29, 2026 | BIO-ATORVASTATIN | Biomed Pharma | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 29, 2026 | EZETIMIBE | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| September 29, 2026 | BORTEZOMIB FOR INJECTION | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 28, 2026 | QALSODY | Biogen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 28, 2026 | LOSARTAN POTASSIUM | Jubilant Generics Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 28, 2026 | PRO-ROSUVASTATIN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 28, 2026 | ONDANSETRON ODT | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| September 28, 2026 | VAQTA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 28, 2026 | ONTRUZANT | Samsung Bioepis Co., Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| September 28, 2026 | NRA-IMATINIB | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 28, 2026 | DAWNZERA | Celystra Pharma Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| September 28, 2026 | SPC-VISMODEGIB | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 28, 2026 | COLUMVI | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 25, 2026 | ZOLYMBUS | Laboratoires Théa | New Drug Submission (NDS) · Other |
| September 25, 2026 | PMS-RUPATADINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 25, 2026 | MAR-FLECAINIDE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 25, 2026 | TARO-SUMATRIPTAN | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 25, 2026 | CEFAZOLIN FOR INJECTION | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 25, 2026 | TEVA-DULOXETINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 25, 2026 | PROVOCHOLINE; PROVOCHOLINE INHALATION SOLUTION; PROVOCHOLINE INHALATION SOLUTION 16 | Methapharm Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 25, 2026 | VISKAZIDE | Xediton Pharmaceuticals Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 25, 2026 | PRO-CIPROFLOXACIN; PRO-CIPROFLOXACIN INTRAVENOUS INFUSION BP | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 25, 2026 | SIBBORAN | Aop Orphan Pharmaceuticals Gmbh | New Drug Submission (NDS) · Admin |
| September 24, 2026 | PMS-BUSPIRONE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 24, 2026 | AA-SUCRALFATE | AA Pharma Inc. | New Drug Submission (NDS) · Labelling Only |
| September 24, 2026 | MINT-CANDESARTAN | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 24, 2026 | AG-CITALOPRAM TABLETS | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 24, 2026 | AURO-RIVASTIGMINE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 24, 2026 | ADVAIR | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 24, 2026 | ANZUPGO | Leo Pharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 24, 2026 | SANDOZ CLONIDINE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 24, 2026 | NB-CIPROFLOXACIN | NB Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 24, 2026 | PROSTALUMIN | Centre For Probe Development And Commercialization | New Drug Submission (NDS) · New Active Substance (NAS) |
| September 24, 2026 | WELIREG | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 24, 2026 | HERNEXEOS | Boehringer Ingelheim (Canada) Ltd. | New Drug Submission (NDS) · New Active Substance (NAS) |
| September 24, 2026 | LIBTAYO | Regeneron Canada Company | Supplement to a New Drug Submission (SNDS) · Other |
| September 24, 2026 | BEXSERO | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 24, 2026 | HALOPERIDOL LA | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 24, 2026 | IMVAMUNE | Bavarian Nordic As | Supplement to a New Drug Submission (SNDS) · Other |
| September 24, 2026 | YESCARTA | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 24, 2026 | IMFINZI | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 24, 2026 | M-CITALOPRAM | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 24, 2026 | CASGEVY | Vertex Pharmaceuticals (Canada) Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| September 23, 2026 | METFORMIN TABLETS | Granules India Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 23, 2026 | NESINA | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| September 23, 2026 | DUPIXENT | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 22, 2026 | DYSPORT THERAPEUTIC | Ipsen Biopharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 22, 2026 | INNOHEP | Leo Pharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 22, 2026 | VEGZELMA | Celltrion Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 22, 2026 | AG-DULOXETINE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 22, 2026 | TRI-SOLFEN | Medical Ethics Pty Ltd | New Drug Submission (NDS) · Admin |
| September 21, 2026 | NRA-RAMIPRIL | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 21, 2026 | REKOVELLE | Ferring Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 21, 2026 | KAZANO | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| September 18, 2026 | JAMP VALPROIC ACID ORAL SOLUTION | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 18, 2026 | TEVA-BUPROPION XL | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 18, 2026 | DULOXETINE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 18, 2026 | JAMP CALCITRIOL | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| September 18, 2026 | TARO-TESTOSTERONE GEL PUMP | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 18, 2026 | PMS-LEVODOPA-CARBIDOPA CR | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 18, 2026 | JAMP LISDEXAMFETAMINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 18, 2026 | IMCIVREE | Rhythm Pharmaceuticals, Inc | Supplement to a New Drug Submission (SNDS) · Priority |
| September 18, 2026 | MINT-BISOPROLOL | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 18, 2026 | RIVA-ISAVUCONAZOLE | Laboratoire Riva Inc. | New Drug Submission (NDS) · Admin |
| September 18, 2026 | MYPREF | Ambicare Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 17, 2026 | FREYA 21; FREYA 28 | Senador Laboratories Private Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| September 17, 2026 | M-ESLON | Ethypharm Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 17, 2026 | SMOFLIPID 20% | Fresenius Kabi Canada Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| September 17, 2026 | FERRIPROX; FERRIPROX MR | Chiesi Canada Corp. | Supplement to a New Drug Submission (SNDS) · Other |
| September 17, 2026 | PAXIL | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 17, 2026 | ZEJULA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 17, 2026 | KISQALI | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 17, 2026 | ENHERTU | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 17, 2026 | REMSIMA SC | Celltrion Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 17, 2026 | EPKINLY | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Priority |
| September 17, 2026 | OCREVUS | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 16, 2026 | PROLEUKIN | Iovance Biotherapeutics Manufacturing Llc | Supplement to a New Drug Submission (SNDS) · Other |
| September 16, 2026 | SANDOZ SEMAGLUTIDE | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| September 16, 2026 | APO-NORETHINDRONE | Apotex Inc. | New Drug Submission (NDS) · Admin |
| September 16, 2026 | JAMP-DULOXETINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 16, 2026 | AMMIVO | Sterimax Inc. | New Drug Submission (NDS) · Priority-NAS |
| September 16, 2026 | APPRILON | Galderma Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 16, 2026 | MELPHALAN FOR INJECTION | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 16, 2026 | YERVOY | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| September 16, 2026 | JAMP-CITALOPRAM | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 16, 2026 | JAMP ARIPIPRAZOLE ORAL SOLUTION | JAMP Pharma Corporation | Supplement to a New Drug Submission (SNDS) · Admin |
| September 16, 2026 | MINT-LAMOTRIGINE | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| September 15, 2026 | IRBESARTAN | Jubilant Generics Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 15, 2026 | TEVA-BILASTINE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| September 15, 2026 | MINT-VALGANCICLOVIR | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 15, 2026 | ODAN-BUPROPION XL | Odan Laboratories Ltd. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 15, 2026 | M-DULOXETINE | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 15, 2026 | NRA-CITALOPRAM | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 15, 2026 | SARCLISA SC | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 15, 2026 | TEVA-LISDEXAMFETAMINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 15, 2026 | COMIRNATY | Biontech Manufacturing Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| September 14, 2026 | METHOHEXITAL SODIUM FOR INJECTION USP | Sterimax Inc. | New Drug Submission (NDS) · Other |
| September 14, 2026 | NEXTSTELLIS | Searchlight Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 14, 2026 | ADEMPAS | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 14, 2026 | GABAPENTIN | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| September 11, 2026 | MINT-SILDENAFIL R | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| September 11, 2026 | GLN-APREMILAST | Glenmark Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 11, 2026 | TREPROSTINIL INJECTION | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 11, 2026 | MINT-ABIRATERONE | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| September 11, 2026 | ESOMEPRAZOLE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 11, 2026 | ACULAR | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| September 11, 2026 | AG-VALACYCLOVIR | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 11, 2026 | AG-ROSUVASTATIN | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 11, 2026 | IBUPROFEN PLUS ACETAMINOPHEN | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 11, 2026 | OPDUALAG | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| September 11, 2026 | FLUMIST | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 11, 2026 | PLUSET | Alberta Veterinary Laboratories Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| September 10, 2026 | CLOPIDOGREL | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 10, 2026 | APO-CYCLOBENZAPRINE | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| September 10, 2026 | SEROSTIM | Emd Serono A Division Of Emd Inc Canada | Supplement to a New Drug Submission (SNDS) · Other |
| September 10, 2026 | OVIDREL | Emd Serono A Division Of Emd Inc Canada | Supplement to a New Drug Submission (SNDS) · Other |
| September 10, 2026 | NUVAXOVID | Sanofi Vaccines Canada Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| September 9, 2026 | CITALOPRAM | Jubilant Generics Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 9, 2026 | FLECAINIDE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 9, 2026 | JAMP ACYCLOVIR | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| September 9, 2026 | VINCRISTINE SULFATE INJECTION | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 9, 2026 | IMURAN | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 9, 2026 | GLN-ATOVAQUONE | Glenmark Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 9, 2026 | MNEXSPIKE | Moderna Biopharma Canada Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| September 9, 2026 | SPC-CLOPIDOGREL | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 8, 2026 | JAMP LEVETIRACETAM SOLUTION | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| September 8, 2026 | EUGIA-ROCURONIUM BROMIDE INJECTION | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 8, 2026 | RIVA-METFORMIN | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 8, 2026 | IMULDOSA; IMULDOSA I.V. | Accord Healthcare Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 8, 2026 | VYVGART; VYVGART SC | Argenx Bv | Supplement to a New Drug Submission (SNDS) · Other |
| September 8, 2026 | COMIRNATY | Biontech Manufacturing Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| September 4, 2026 | PMS-VALPROIC ACID; PMS-VALPROIC ACID E.C. | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 4, 2026 | JAMP DIVALPROEX | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 4, 2026 | SUPREFACT | Cheplapharm Arzneimittel Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| September 4, 2026 | VERZENIO | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 4, 2026 | PERIDEX ORAL RINSE | Solventum Canada Limited | New Drug Submission (NDS) · Labelling Only |
| September 4, 2026 | NRA-GABAPENTIN | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 4, 2026 | ROSUVASTATIN | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 3, 2026 | SILDENAFIL CITRATE | Jubilant Generics Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 3, 2026 | AURO-CARBAMAZEPINE | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 3, 2026 | APO-TADALAFIL PAH | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 3, 2026 | OLMETEC PLUS | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 3, 2026 | EMLA CREAM | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 3, 2026 | MAR-RAMIPRIL | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 2, 2026 | STALEVO | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 2, 2026 | COMIRNATY | Biontech Manufacturing Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| September 2, 2026 | PLUVICTO | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 2, 2026 | TRIMBOW | Chiesi Farmaceutici S.P.A. | Supplement to a New Drug Submission (SNDS) · Other |
| September 2, 2026 | NRA-RIVAROXABAN | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 2, 2026 | GILENYA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 2, 2026 | SPC-DESVENLAFAXINE | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 2, 2026 | TARO-METHYLPHENIDATE ER | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 1, 2026 | GLASSIA | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| September 1, 2026 | OLANZAPINE-ODT | Jubilant Generics Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 1, 2026 | MAYZENT | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 1, 2026 | CANDESARTAN | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 1, 2026 | FLUVIRAL | Id Biomedical Corporation Of Quebec | Supplement to a New Drug Submission (SNDS) · Other |
| September 1, 2026 | AG-RAMIPRIL | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 1, 2026 | FLUZONE; FLUZONE HIGH-DOSE | Sanofi Vaccines Canada Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| September 1, 2026 | JAMP RAMIPRIL | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 1, 2026 | PRO-SUMATRIPTAN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 1, 2026 | JAMP TOBRAMYCIN / DEXAMETHASONE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| August 31, 2026 | FLULAVAL TETRA | Id Biomedical Corporation Of Quebec | Supplement to a New Drug Submission (SNDS) · Other |
| August 31, 2026 | TARO-PEMETREXED | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 31, 2026 | RAMIPRIL | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 31, 2026 | NRA-MONTELUKAST | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 31, 2026 | NB-EZETIMIBE | NB Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 28, 2026 | PAXLOVID | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| August 28, 2026 | FLUCELVAX | Seqirus Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 28, 2026 | BOSAYA | Biocon Biologics Canada Inc | New Drug Submission (NDS) · Admin |
| August 28, 2026 | IPRATROPIUM BROMIDE AND SALBUTAMOL SULPHATE INHALATION SOLUTION | Juno Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 28, 2026 | KETOROLAC TROMETHAMINE INJECTION, USP | Juno Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 28, 2026 | JAMP METRONIDAZOLE GEL | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| August 28, 2026 | SAIZEN | Emd Serono A Division Of Emd Inc Canada | Supplement to a New Drug Submission (SNDS) · Other |
| August 28, 2026 | SPIKEVAX | Moderna Biopharma Canada Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| August 28, 2026 | ADVIL COLD & SINUS EXTRA STRENGTH LIQUI-GELS; ADVIL COLD & SINUS LIQUI-GELS; ADVIL COLD AND SINUS; ADVIL COLD AND SINUS DAYTIME; CHILDREN'S ADVIL COLD | Haleon Canada ULC | Supplement to a New Drug Submission (SNDS) · Other |
| August 28, 2026 | VEVZUO | Biocon Biologics Canada Inc | New Drug Submission (NDS) · Admin |
| August 27, 2026 | TEVA-VALACYCLOVIR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 27, 2026 | VORICONAZOLE FOR INJECTION | Formative Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 27, 2026 | VORICONAZOLE FOR INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 27, 2026 | MINT-LOSARTAN | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 27, 2026 | APO-VALACYCLOVIR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 27, 2026 | FLAGYL | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 27, 2026 | LEQVIO | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 27, 2026 | VIACORAM | Servier Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 27, 2026 | COVERSYL PLUS; COVERSYL PLUS HD; COVERSYL PLUS LD | Servier Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 27, 2026 | COVERSYL | Servier Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 27, 2026 | CLINDAMYCIN INJECTION USP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 27, 2026 | TEVA-SACUBITRIL / VALSARTAN | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| August 27, 2026 | AZACITIDINE FOR INJECTION | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 27, 2026 | RYLAZE | Jazz Pharmaceuticals Ireland Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 27, 2026 | YESCARTA | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 27, 2026 | RYBREVANT | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 27, 2026 | ENHERTU | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Priority |
| August 27, 2026 | JAMP TOLTERODINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 27, 2026 | MAR-CITALOPRAM | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 27, 2026 | MINT-LOSARTAN/HCTZ; MINT-LOSARTAN/HCTZ DS | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 27, 2026 | ARSENIC TRIOXIDE SOLUTION FOR INJECTION | Phebra Pty Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 27, 2026 | VORICONAZOLE FOR INJECTION | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 27, 2026 | IPG-CITALOPRAM | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 26, 2026 | VITRAKVI | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 26, 2026 | FRUZAQLA | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| August 26, 2026 | ISTURISA | Recordati Rare Diseases Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 26, 2026 | JAMP FOSFOMYCIN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 26, 2026 | JAMP DOXEPIN TABLETS | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 26, 2026 | TEVA-SUMATRIPTAN; TEVA-SUMATRIPTAN DF | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 26, 2026 | ACCEL-APREMILAST | Accel Pharma Inc | Abbreviated New Drug Submission (ANDS) · Other |
| August 26, 2026 | JAMP DOXEPIN TABLETS | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| August 25, 2026 | AMGEVITA | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 25, 2026 | KOVALTRY | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 25, 2026 | APO-TRIAZIDE | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 25, 2026 | SEMAGLUTIDE INJECTION | Aspen Pharmacare Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 24, 2026 | PAXIL CR | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 24, 2026 | QUINSAIR | Chiesi Farmaceutici S.P.A. | New Drug Submission (NDS) · Admin |
| August 21, 2026 | TOBRAMYCIN INJECTION, USP | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 21, 2026 | MINT-GALANTAMINE ER | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| August 21, 2026 | FLAGYSTATIN | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 21, 2026 | DOVOBET GEL; DOVOBET OINTMENT | Leo Pharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 21, 2026 | JAMP TOFACITINIB | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 21, 2026 | APO-DIVALPROEX | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 21, 2026 | DOXYTAB | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Admin |
| August 21, 2026 | VYVGART SC | Argenx Bv | Supplement to a New Drug Submission (SNDS) · Other |
| August 21, 2026 | IMATINIB | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 21, 2026 | IMFINZI | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 20, 2026 | CLINDAMYCIN IV INFUSION | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 20, 2026 | DALACIN C PHOSPHATE | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| August 20, 2026 | CARBOPLATIN INJECTION BP | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 20, 2026 | NDUVRA | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 20, 2026 | SANDOZ APIXABAN TABLET | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 20, 2026 | KADIAN | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| August 20, 2026 | ACH-ROSUVASTATIN | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 20, 2026 | HALOPERIDOL INJECTION | Juno Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 19, 2026 | MRESVIA | Moderna Biopharma Canada Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| August 19, 2026 | CYCLOBENZAPRINE | Sanis Health Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| August 19, 2026 | ZORYVE | Arcutis Canada, Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 19, 2026 | PROPOFOL INJECTION | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 19, 2026 | ATORVASTATIN-10; ATORVASTATIN-20; ATORVASTATIN-40; ATORVASTATIN-80 | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 19, 2026 | TARO-DOXEPIN | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| August 19, 2026 | JAMP NINTEDANIB | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 19, 2026 | APO-VARENICLINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 19, 2026 | BIMATOPROST RC | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 19, 2026 | OPDIVO SC | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| August 18, 2026 | LEMTRADA | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 18, 2026 | LAZCLUZE | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 18, 2026 | TEVA-QUETIAPINE XR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 18, 2026 | PROVOCHOLINE; PROVOCHOLINE INHALATION SOLUTION | Methapharm Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 18, 2026 | APO-TADALAFIL | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 18, 2026 | JAMP-ASA 81MG EC | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 18, 2026 | TEVA-FLUTICASONE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 18, 2026 | EVRA | Searchlight Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 18, 2026 | PENTHROX | Knight Therapeutics Inc. | New Drug Submission (NDS) · Admin |
| August 18, 2026 | PRO-CYCLOBENZAPRINE | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Admin |
| August 17, 2026 | KAVIGALE | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 17, 2026 | LUNSUMIO; LUNSUMIO SC | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 14, 2026 | PMS-ENZALUTAMIDE | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 14, 2026 | FABHALTA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 14, 2026 | APO-FELODIPINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 14, 2026 | CERTICAN | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 14, 2026 | GLYCON | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 14, 2026 | FULPHILA | Biocon Biologics Canada Inc | New Drug Submission (NDS) · Admin |
| August 14, 2026 | TREMFYA; TREMFYA ONE-PRESS | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 14, 2026 | PMS-METRONIDAZOLE GEL | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| August 13, 2026 | OCTAPLEX | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| August 13, 2026 | IMAAVY | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 13, 2026 | LEFLUNOMIDE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 12, 2026 | LUPIN-SODIUM CROMOGLICATE | Lupin Pharma Canada Limited | New Drug Submission (NDS) · Admin |
| August 12, 2026 | BLEOMYCIN FOR INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 12, 2026 | ELIGARD | Tolmar International Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| August 12, 2026 | BRIMONIDINE-TIMOLOL | Micro Labs Limited | Abbreviated New Drug Submission (ANDS) · Other |
| August 12, 2026 | LYNKUET | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 12, 2026 | JAMP MIRTAZAPINE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| August 12, 2026 | MINT-TADALAFIL | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| August 12, 2026 | TEVA-FENTANYL | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 12, 2026 | SUNLENCA | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 12, 2026 | VEOZAH | Astellas Pharma Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 12, 2026 | JALYN | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 12, 2026 | QOSEQU | Mantra Pharma Inc. | New Drug Submission (NDS) · Other |
| August 12, 2026 | TARO-CLINDAMYCIN/BENZOYL PEROXIDE GEL | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 12, 2026 | NORTRIPTYLINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 12, 2026 | NAT-EVEROLIMUS | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 12, 2026 | ASA 81 MG | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 12, 2026 | JINARC | Otsuka Pharmaceutical Co Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| August 12, 2026 | CRESTOR | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 12, 2026 | AVODART | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 12, 2026 | PROGESTERONE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 11, 2026 | GALANTAMINE ER | Essential Pharma Switzerland Gmbh | New Drug Submission (NDS) · Labelling Only |
| August 11, 2026 | SPC-ESTRADIOL 10 | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 11, 2026 | JAMP TOFACITINIB | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 10, 2026 | COMIRNATY | Biontech Manufacturing Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| August 10, 2026 | ZEULIDE DEPOT | Verity Pharmaceuticals Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 10, 2026 | ABEVMY | Biocon Biologics Canada Inc | New Drug Submission (NDS) · Admin |
| August 10, 2026 | RIVA-ISMN | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 7, 2026 | KOSELUGO; KOSELUGO GRANULES | Alexion Pharma Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| August 7, 2026 | GIVLAARI | Alnylam Netherlands B.V. | Supplement to a New Drug Submission (SNDS) · Other |
| August 7, 2026 | ZOLMITRIPTAN-ODT | Jubilant Generics Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 7, 2026 | GLN-URSODIOL | Glenmark Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 7, 2026 | TEVA-PINDOLOL | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 7, 2026 | APO-SUMATRIPTAN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 7, 2026 | JAMP-ZOLEDRONIC ACID | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 7, 2026 | ZOPICLONE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 7, 2026 | AG-GUANFACINE XR | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 7, 2026 | EUGIA-ABIRATERONE | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 7, 2026 | NB-OLANZAPINE | NB Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| August 7, 2026 | PMS-AZITHROMYCIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 7, 2026 | PRO-GABAPENTIN | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| August 7, 2026 | APIXABAN | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| August 6, 2026 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Jubilant Generics Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 6, 2026 | ODAN LIDOCAINE-PRILOCAINE CREAM | Odan Laboratories Ltd. | Abbreviated New Drug Submission (ANDS) · Other |
| August 6, 2026 | HEMANGIOL | Pierre Fabre Dermo-Cosmetique Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 6, 2026 | PERINDOPRIL/INDAPAMIDE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 6, 2026 | PRO-LEFLUNOMIDE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 6, 2026 | AG-CANDESARTAN HCT | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 6, 2026 | PRO-ZOPICLONE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 6, 2026 | APO-BILASTINE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 6, 2026 | PLOSBRIO | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Admin |
| August 5, 2026 | AG-TICAGRELOR | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 5, 2026 | RIVA-CITALOPRAM | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 5, 2026 | TOVIAZ | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| August 5, 2026 | ERLEADA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 5, 2026 | NRA-ZOPICLONE | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 5, 2026 | MYCOPHENOLATE MOFETIL | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 5, 2026 | M-SITAGLIPTIN-METFORMIN | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 5, 2026 | M-RIZATRIPTAN | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 5, 2026 | WELIREG | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 5, 2026 | FASENRA; FASENRA PEN | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 5, 2026 | PMS-ESOMEPRAZOLE DR | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 5, 2026 | TAMIFLU | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 5, 2026 | ADVIL COLD AND SINUS NIGHTTIME; ADVIL COLD, SINUS & FLU EXTRA STRENGTH; CHILDREN'S ADVIL COLD & FLU MULTI-SYMPTOM; ADVIL COLD & SINUS PLUS | Haleon Canada ULC | Supplement to a New Drug Submission (SNDS) · Other |
| August 5, 2026 | ULTOMIRIS | Alexion Pharma Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| August 4, 2026 | MYLAN-DIVALPROEX | Mylan Pharmaceuticals Ulc | Supplement to a New Drug Submission (SNDS) · Admin |
| August 4, 2026 | ETCAMAH | Astrazeneca Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| August 4, 2026 | PRO-DOXYLAMINE-PYRIDOXINE | Pro Doc Limitee | New Drug Submission (NDS) · Admin |
| August 4, 2026 | TYENNE | Fresenius Kabi Canada Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| August 4, 2026 | HYOSCINE BUTYLBROMIDE INJECTION | As Kalceks | Abbreviated New Drug Submission (ANDS) · Admin |
| August 4, 2026 | SEMGLEE | Biocon Sdn.Bhd | Supplement to a New Drug Submission (SNDS) · Other |
| August 4, 2026 | KESIMPTA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 4, 2026 | AVTOZMA | Celltrion Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 4, 2026 | CITALOPRAM | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 1, 2026 | FLUAD | Seqirus Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 31, 2026 | GLEOLAN | Medexus Pharmaceuticals Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 31, 2026 | TEGRETOL; TEGRETOL CR; TEGRETOL SUSPENSION | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 31, 2026 | M-IRBESARTAN | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| July 31, 2026 | CYCLOPHOSPHAMIDE FOR INJECTION USP | Formative Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| July 31, 2026 | TECENTRIQ; TECENTRIQ SC | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 31, 2026 | TECVAYLI | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Priority |
| July 31, 2026 | REBIF | Emd Serono A Division Of Emd Inc Canada | Supplement to a New Drug Submission (SNDS) · Other |
| July 31, 2026 | TEVA-LEFLUNOMIDE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 31, 2026 | AG-ZOPICLONE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 31, 2026 | RIVA-ZOPICLONE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 31, 2026 | COLD + SINUS | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 30, 2026 | NUBEQA | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 30, 2026 | PRO-BISOPROLOL | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 30, 2026 | ENTRESTO | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 30, 2026 | RAPAMUNE | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| July 30, 2026 | GLYCOPYRROLATE INJECTION USP (PRESERVATIVE FREE); GLYCOPYRROLATE INJECTION USP (WITH PRESERVATIVE) | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 30, 2026 | NEORAL; SANDIMMUNE I.V. | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 30, 2026 | PMS-TOFACITINIB | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 30, 2026 | MINT-DULOXETINE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 29, 2026 | ALOG-SAPROPTERIN | Analog Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 29, 2026 | PRO-GUANFACINE XR | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 29, 2026 | ALTA-ZOPICLONE | Altamed Pharma | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 29, 2026 | AG-RIVAROXABAN | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 29, 2026 | ACETYLCYSTEINE SOLUTION USP | Hikma Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 29, 2026 | SILDENAFIL CITRATE | 10445517 Canada Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| July 29, 2026 | PDP-DESONIDE | Pendopharm Division Of Pharmascience Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 29, 2026 | AMBELVIST | Bayer Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| July 29, 2026 | MINT-TIZANIDINE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 29, 2026 | SKYRIZI | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| July 29, 2026 | AZARGA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 29, 2026 | AVSOLA | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 28, 2026 | GLUMETZA; GLUMETZA (SB) | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 28, 2026 | RIVAROXABAN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 28, 2026 | SPC-FENOFIBRATE E | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 28, 2026 | AURO-METHOTREXATE TABLETS | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 28, 2026 | APO-CITALOPRAM | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 28, 2026 | JAMP-ZOPICLONE TABLETS | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 28, 2026 | MINOXIDIL 5% MEN / HOMMES | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| July 28, 2026 | BUTOMIDOR | Vetviva Richter Gmbh | Abbreviated New Drug Submission (ANDS) · Other |
| July 27, 2026 | MICAFUNGIN SODIUM FOR INJECTION | Juno Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 27, 2026 | NB-RIVAROXABAN | NB Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 27, 2026 | PRO-CITALOPRAM | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 27, 2026 | NAT-PALBOCICLIB | Natco Pharma (Canada) Inc | Abbreviated New Drug Submission (ANDS) · Other |
| July 24, 2026 | GLYCOPYRROLATE INJECTION USP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 24, 2026 | AURO-ROSUVASTATIN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 24, 2026 | SANDOZ VALACYCLOVIR | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 24, 2026 | MAR- MYCOPHENOLATE MOFETIL | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 24, 2026 | SANDOZ VORICONAZOLE; VORICONAZOLE FOR INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 24, 2026 | JAMP VORICONAZOLE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 24, 2026 | AURO-BETAHISTINE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 24, 2026 | AA-MEDROXY | AA Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 24, 2026 | JAMP RAMIPRIL CAPSULES | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| July 24, 2026 | VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 24, 2026 | TARO-CANDESARTAN | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 24, 2026 | M-AMBRISENTAN | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 24, 2026 | DULOXETINE | Alembic Pharmaceuticals Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 23, 2026 | AG-LISDEXAMFETAMINE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 23, 2026 | ALERTEC | Neuraxpharm Pharmaceuticals, S.L. | New Drug Submission (NDS) · Admin |
| July 23, 2026 | SUMATRIPTAN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 23, 2026 | AG-ALMOTRIPTAN | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 23, 2026 | TECFIDERA | Biogen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 23, 2026 | ESTROGEL | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 23, 2026 | JAKAVI | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 23, 2026 | SULFATRIM; SULFATRIM DS; SULFATRIM PEDIATRIC | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 23, 2026 | NRA-METFORMIN TABLETS | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 23, 2026 | SHINGRIX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 23, 2026 | ALFAGLANDIN C | Alfasan Nederland B.V. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 22, 2026 | SEPHIENCE | Ptc Therapeutics International Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 22, 2026 | NB-IRBESARTAN HCT | NB Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 22, 2026 | SATIVEX | Cnx Therapeutics Limited | New Drug Submission (NDS) · Admin |
| July 22, 2026 | RIVA-METFORMIN | Laboratoire Riva Inc. | New Drug Submission (NDS) · Admin |
| July 22, 2026 | NRA-HYDROXYCHLOROQUINE | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 22, 2026 | COMBIVENT RESPIMAT | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| July 22, 2026 | ERLEADA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 22, 2026 | FENTORA | Phoenix Labs Unlimited Company | New Drug Submission (NDS) · Admin |
| July 22, 2026 | M-ZOPICLONE | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 21, 2026 | DEVATIS TOFACITINIB | Devatis Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| July 21, 2026 | SANDOZ ANASTROZOLE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 21, 2026 | SANDOZ LEVETIRACETAM | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 21, 2026 | DIFLUCAN | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| July 21, 2026 | LOTRIDERM | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 21, 2026 | PMS-NIFEDIPINE ER | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 21, 2026 | ESCITALOPRAM | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 21, 2026 | APO-SUMATRIPTAN-NAPROXEN SODIUM | Apotex Inc. | New Drug Submission (NDS) · Admin |
| July 21, 2026 | AURO-METFORMIN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 21, 2026 | VAXNEUVANCE | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 21, 2026 | PROLIA | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 20, 2026 | ALTA-CLOPIDOGREL | Altamed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| July 20, 2026 | KEYTRUDA SC | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 20, 2026 | TRYNGOLZA | Celystra Pharma Inc. | New Drug Submission (NDS) · Admin |
| July 20, 2026 | AURO-DULOXETINE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 20, 2026 | TEVA-RASAGILINE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 20, 2026 | SANDOZ FENOFIBRATE E | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 20, 2026 | PRO-IRBESARTAN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 20, 2026 | AG-OMEPRAZOLE DR | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 20, 2026 | XEOMIN; XEOMIN COSMETIC | Merz Pharmaceuticals Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| July 20, 2026 | EYDENZELT | Celltrion Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 20, 2026 | ILLUCCIX | Telix Pharmaceuticals (Us) Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 20, 2026 | PRALUENT | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 20, 2026 | TZIELD | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 20, 2026 | ADCETRIS | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| July 17, 2026 | ATACAND | Cheplapharm Arzneimittel Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| July 17, 2026 | RIVAROXABAN | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 17, 2026 | IMATINIB | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 17, 2026 | ASPEN-SEMAGLUTIDE | Aspen Pharmacare Canada Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| July 17, 2026 | AURO-DULOXETINE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 17, 2026 | METVIX | Galderma Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 17, 2026 | ALECENSARO | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 17, 2026 | DULOXETINE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 16, 2026 | SANDOZ SITAGLIPTIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 16, 2026 | RHAPSIDO | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| July 16, 2026 | ITOVEBI | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 16, 2026 | VTRS-ELETRIPTAN | Mylan Pharmaceuticals Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| July 16, 2026 | AURO-AMBRISENTAN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 16, 2026 | SANDOZ FELODIPINE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 16, 2026 | AG-BIMATOPROST RC | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 16, 2026 | SYNCROPROST | Ceva Animal Health Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 15, 2026 | CODEINE CONTIN | Purdue Pharma | Supplement to a New Drug Submission (SNDS) · Other |
| July 15, 2026 | BIPHENTIN | Elvium Life Sciences | Supplement to a New Drug Submission (SNDS) · Other |
| July 15, 2026 | RIVA-ABIRATERONE | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 15, 2026 | NB-CITALOPRAM | NB Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 15, 2026 | EPRINOVET | Modern Veterinary Therapeutics Llc | Abbreviated New Drug Submission (ANDS) · Other |
| July 15, 2026 | CANINSULIN | Intervet Canada Corp | Supplement to a New Drug Submission (SNDS) · Other |
| July 15, 2026 | REMDANTRY | Celltrion Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 14, 2026 | KALETRA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| July 14, 2026 | NORVIR | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| July 14, 2026 | RINVOQ | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| July 14, 2026 | YESINTEK | Biocon Biologics Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 14, 2026 | DIARRHEA RELIEF | Vita Health Products Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 14, 2026 | TRELSTAR | Knight Therapeutics Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 13, 2026 | JAMP-AMOXICILLIN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 13, 2026 | TEVA-ATORVASTATIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 13, 2026 | MYLAN-VALACYCLOVIR | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 13, 2026 | TEVA-MYCOPHENOLATE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 13, 2026 | JAMP VALACYCLOVIR | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 13, 2026 | SANDOZ ROSUVASTATIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 13, 2026 | TEVA-ROSUVASTATIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 13, 2026 | AURO-VORICONAZOLE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 13, 2026 | OJEMDA | Ipsen Biopharmaceuticals Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| July 13, 2026 | NB-DULOXETINE | NB Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 13, 2026 | PRO-ATOMOXETINE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 13, 2026 | ZOPICLONE | Sivem Pharmaceuticals Ulc | Supplement to a New Drug Submission (SNDS) · Admin |
| July 13, 2026 | OZEMPIC | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 13, 2026 | RYBELSUS | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 13, 2026 | NGENLA | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| July 13, 2026 | LIBTAYO | Regeneron Canada Company | Supplement to a New Drug Submission (SNDS) · Other |
| July 10, 2026 | TEPEZZA | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 10, 2026 | AURO-DAPAGLIFLOZIN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 10, 2026 | M-TICAGRELOR | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 10, 2026 | JAMP ROSUVASTATIN TABLETS | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 10, 2026 | TEVA-IRBESARTAN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 10, 2026 | MINT-IRBESARTAN | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 10, 2026 | APO-TICAGRELOR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 10, 2026 | RIVA-ATORVASTATIN | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 10, 2026 | APO-DAPAGLIFLOZIN-METFORMIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 10, 2026 | ODENSIFY | JAMP Pharma Corporation | New Drug Submission (NDS) · Other |
| July 10, 2026 | XDENO | JAMP Pharma Corporation | New Drug Submission (NDS) · Other |
| July 10, 2026 | MOVISSE | Senador Laboratories Private Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| July 10, 2026 | TEVA-DILTIAZEM CD | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 10, 2026 | GABAPENTIN ORAL SOLUTION | Rubicon Research Canada Limited | New Drug Submission (NDS) · Other |
| July 10, 2026 | JAMP RISPERIDONE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 10, 2026 | SKYRIZI | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| July 10, 2026 | EMPAVELI | Swedish Orphan Biovitrum Ab (Publ) | Supplement to a New Drug Submission (SNDS) · Other |
| July 10, 2026 | APO-METOPROLOL; APO-METOPROLOL (TYPE L) | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 10, 2026 | COLUMVI | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 10, 2026 | TRINTELLIX | Lundbeck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 10, 2026 | ODAN-VALPROIC ACID | Odan Laboratories Ltd. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 10, 2026 | NITROLINGUAL PUMPSPRAY | G. Pohl-Boskamp GmbH & Co. KG | New Drug Submission (NDS) · Admin |
| July 10, 2026 | BUPROPION HYDROCHLORIDE XL | Yichang Humanwell Pharmaceuticals Co., Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 9, 2026 | SCENESSE | Clinuvel, Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| July 9, 2026 | MINT-PIOGLITAZONE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 9, 2026 | OPZELURA | Incyte Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| July 9, 2026 | JAMP AMBRISENTAN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 8, 2026 | INDAYO | Senador Laboratories Private Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| July 8, 2026 | JOENJA | Pharming Technologies B.V. | New Drug Submission (NDS) · Priority-NAS |
| July 8, 2026 | CYSTADANE | Recordati Rare Diseases Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 8, 2026 | CARBETOCIN INJECTION | Juno Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 8, 2026 | SKYRIZI | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| July 8, 2026 | VYEPTI | Lundbeck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 8, 2026 | TRODELVY | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 8, 2026 | YESCARTA | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 7, 2026 | SOHONOS | Ipsen Biopharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 7, 2026 | TOBRAMYCIN INJECTION USP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 7, 2026 | TEVA-OMEPRAZOLE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 6, 2026 | MAR-ZOPICLONE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 6, 2026 | M-CELECOXIB | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 6, 2026 | DEXRAZOXANE FOR INJECTION | Juno Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 6, 2026 | INTRA HOOF-FIT GEL | Intracare Bv | Supplement to a New Drug Submission (SNDS) · Other |
| July 6, 2026 | MAR-LEFLUNOMIDE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 6, 2026 | AURO-DAPAGLIFLOZIN / METFORMIN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 3, 2026 | TALTZ | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 3, 2026 | NEUPOGEN | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 3, 2026 | NEULASTA | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 3, 2026 | EFUDEX | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 3, 2026 | CISATRACURIUM BESYLATE INJECTION USP MULTI-DOSE | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 3, 2026 | TEVA-TOLTERODINE LA | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 3, 2026 | SEPTRA INJECTION; SEPTRA PEDIATRIC ORAL SUSPENSION | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 3, 2026 | AG-HYDROXYCHLOROQUINE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 3, 2026 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| July 3, 2026 | IMFINZI | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 3, 2026 | SANDOZ IRBESARTAN HCT | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 2, 2026 | IMDELLTRA | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 2, 2026 | EPYSQLI | Samsung Bioepis Co., Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| July 2, 2026 | KOSELUGO GRANULES | Alexion Pharma Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| July 2, 2026 | EXELON | Knight Therapeutics Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 2, 2026 | XGEVA | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 2, 2026 | NEXPLANON | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 2, 2026 | SPORANOX | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 2, 2026 | DARZALEX; DARZALEX SC | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 2, 2026 | AG-CELECOXIB | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 2, 2026 | DILTIAZEM HYDROCHLORIDE INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 2, 2026 | VANRAFIA | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| July 2, 2026 | BESREMI | Forus Therapeutics Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| June 30, 2026 | WINLEVI | Sun Pharmaceutical Industries Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 30, 2026 | PENTASA | Ferring Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 30, 2026 | NINLARO | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| June 30, 2026 | SPC-IRBESARTAN | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 30, 2026 | MINT-BRIVARACETAM | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| June 30, 2026 | AURO-PERINDOPRIL/INDAPAMIDE | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 30, 2026 | ASN-CEPHALEXIN | Ascend Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 30, 2026 | IDARUBICIN | Pfizer Canada Ulc | New Drug Submission (NDS) · Labelling Only |
| June 30, 2026 | CLOPIXOL; CLOPIXOL ACUPHASE; CLOPIXOL DEPOT | Lundbeck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 30, 2026 | PRO-RIVAROXABAN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 30, 2026 | M-DILTIAZEM CD | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 30, 2026 | MINT-TOPIRAMATE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 30, 2026 | RIVA RIVAROXABAN | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 30, 2026 | KYZATREX | Hikma Canada Limited | New Drug Submission (NDS) · Admin |
| June 30, 2026 | CARBOPROST TROMETHAMINE INJECTION USP | Juno Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 30, 2026 | HYDROXYCHLOROQUINE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 30, 2026 | NRA-TOPIRAMATE | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 30, 2026 | VARILRIX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 30, 2026 | SAIZEN | Emd Serono A Division Of Emd Inc Canada | Supplement to a New Drug Submission (SNDS) · Other |
| June 29, 2026 | LIVTENCITY | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| June 29, 2026 | ZEPZELCA | Jazz Pharmaceuticals Ireland Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 29, 2026 | HIZENTRA | Csl Behring Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 29, 2026 | AG-QUETIAPINE FUMARATE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 29, 2026 | RADICAVA | Shionogi Inc | New Drug Submission (NDS) · Admin |
| June 29, 2026 | NRA-TELMISARTAN | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 29, 2026 | ZOLMITRIPTAN | Jubilant Generics Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 29, 2026 | BISOPROLOL | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 29, 2026 | M-PROGESTERONE | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 29, 2026 | CEENU | Septa Pharmaceuticals Inc | New Drug Submission (NDS) · Admin |
| June 29, 2026 | SEVMIA | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 26, 2026 | FLUOROURACIL INJECTION | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 26, 2026 | SANDOZ TACROLIMUS | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 26, 2026 | TEVA-LISINOPRIL (TYPE Z) | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 26, 2026 | ISTODAX | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| June 26, 2026 | LANSOPRAZOLE; LANSOPRAZOLE FDT | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 26, 2026 | AG-CITALOPRAM | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 26, 2026 | AMIKACIN SULFATE INJECTION USP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 26, 2026 | TASIGNA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 26, 2026 | ZURZUVAE | Biogen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 26, 2026 | EDARAVONE | Shionogi Canada Inc. | New Drug Submission (NDS) · Admin |
| June 26, 2026 | GAMUNEX | Grifols Therapeutics Llc | Supplement to a New Drug Submission (SNDS) · Other |
| June 26, 2026 | IGIVNEX | Grifols Therapeutics Llc | Supplement to a New Drug Submission (SNDS) · Other |
| June 26, 2026 | PADCEV | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Priority |
| June 26, 2026 | VIMKUNYA | Bavarian Nordic As | New Drug Submission (NDS) · New Active Substance (NAS) |
| June 25, 2026 | INVEGA SUSTENNA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 25, 2026 | IMDELLTRA | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 24, 2026 | TARO-IMATINIB | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 24, 2026 | BRAFTOVI | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| June 24, 2026 | OGIVRI | Biosimilar Collaborations Ireland Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 24, 2026 | EXELON PATCH 10; EXELON PATCH 15; EXELON PATCH 5 | Knight Therapeutics Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 24, 2026 | SHINGRIX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 24, 2026 | OXLUMO | Alnylam Netherlands B.V. | Supplement to a New Drug Submission (SNDS) · Other |
| June 24, 2026 | UBRELVY | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| June 24, 2026 | ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE INJECTION | Pierrel S.P.A. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 24, 2026 | APO-CEFUROXIME | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 24, 2026 | CELECOXIB | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 24, 2026 | JAMP RABEPRAZOLE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 24, 2026 | AURO-CLONIDINE | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 24, 2026 | AG-PRAVASTATIN TABLETS | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 24, 2026 | CITALOPRAM | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 23, 2026 | AKEEGA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 23, 2026 | LIBTAYO | Regeneron Canada Company | Supplement to a New Drug Submission (SNDS) · Other |
| June 23, 2026 | MOUNJARO; MOUNJARO KWIKPEN | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 23, 2026 | DALACIN C FLAVOURED GRANULES | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| June 23, 2026 | PRO-ATORVASTATIN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 23, 2026 | AMLODIPINE | Jubilant Generics Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 23, 2026 | MAR-TEMOZOLOMIDE | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 23, 2026 | NB-LEVETIRACETAM | NB Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 23, 2026 | MYCOPHENOLATE MOFETIL | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| June 23, 2026 | AG-RISPERIDONE | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 23, 2026 | SANDOZ SACUBITRIL-VALSARTAN | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| June 23, 2026 | APO-CITALOPRAM | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 23, 2026 | MINT-LEVOCARB | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 22, 2026 | GLN-NINTEDANIB | Glenmark Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 22, 2026 | SPC-GANIRELIX | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 22, 2026 | ZOPICLONE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 22, 2026 | AG-IRBESARTAN | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 22, 2026 | BOEY | AbbVie Corporation | New Drug Submission (NDS) · New Active Substance (NAS) |
| June 19, 2026 | BUPROPION HCL XL | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| June 19, 2026 | TOPIRAMATE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 19, 2026 | M-ATORVASTATIN | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 19, 2026 | JAMP DILTIAZEM CD | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 19, 2026 | NRA-ATORVASTATIN | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 19, 2026 | AG-TOPIRAMATE TABLETS | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 19, 2026 | NB-APIXABAN TABLET | NB Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 19, 2026 | FULVESTRANT INJECTION | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 19, 2026 | DIENOGEST | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 19, 2026 | AJOVY | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 19, 2026 | FLUMIST | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 18, 2026 | APO-FINGOLIMOD | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 18, 2026 | JAMP DULOXETINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 18, 2026 | JAMP TACROLIMUS OINTMENT | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| June 18, 2026 | RYBREVANT; RYBREVANT SC | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 18, 2026 | TEVA-TAMOXIFEN | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 18, 2026 | PRO-TOPIRAMATE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 17, 2026 | EPYSQLI | Samsung Bioepis Co., Ltd | New Drug Submission (NDS) · Other |
| June 17, 2026 | WELIREG | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 17, 2026 | MARCAINE | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| June 17, 2026 | AJOVY | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 16, 2026 | CLINDAMYCIN INJECTION USP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 16, 2026 | ZYPREXA; ZYPREXA INTRAMUSCULAR; ZYPREXA ZYDIS | Cheplapharm Registration Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| June 16, 2026 | KUVAN | Biomarin International Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 16, 2026 | VASOTEC | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 16, 2026 | ENZEEVU | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 16, 2026 | OMVOH | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 16, 2026 | OPDIVO; OPDIVO SC | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| June 16, 2026 | TEVA-MOMETASONE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 16, 2026 | EUGIA-PROGESTERONE | Eugia Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 16, 2026 | TEVA-BISOPROLOL | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 16, 2026 | PRO-ENZALUTAMIDE | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| June 16, 2026 | HULIO | Biocon Biologics Canada Inc | New Drug Submission (NDS) · Admin |
| June 16, 2026 | DILTIAZEM CD | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 15, 2026 | BUPIVACAINE HYDROCHLORIDE INJECTION USP | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| June 15, 2026 | EXDENSUR | Glaxosmithkline Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| June 13, 2026 | SPC-ATORVASTATIN | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 12, 2026 | PIMJETMI | Emd Serono A Division Of Emd Inc Canada | New Drug Submission (NDS) · Priority-NAS |
| June 12, 2026 | ALTA-DULOXETINE | Altamed Pharma | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 12, 2026 | SANDOZ MIGLUSTAT | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 12, 2026 | VABOMERE | Xediton Pharmaceuticals Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 12, 2026 | SOLUFY | Orimed Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 12, 2026 | MAR-DULOXETINE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 12, 2026 | BRIVLERA | Ucb Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 12, 2026 | AG-CETIRIZINE TABLETS | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 12, 2026 | PEXEGRA | JAMP Pharma Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| June 12, 2026 | COSENTYX | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 12, 2026 | BREYANZI | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| June 12, 2026 | OPDUALAG | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| June 11, 2026 | CONCERTA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 11, 2026 | ZEPBOUND | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 11, 2026 | PRUCALOPRIDE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 10, 2026 | SANDOZ TOFACITINIB | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 10, 2026 | IPG-RAMIPRIL | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 10, 2026 | REDDY-ATORVASTATIN | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 10, 2026 | LUPIN-GLUCAGON | Lupin Pharma Canada Limited | New Drug Submission (NDS) · Other |
| June 10, 2026 | ARIXTRA | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 10, 2026 | RANVU | Apotex Inc. | New Drug Submission (NDS) · Other |
| June 10, 2026 | SARCLISA | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 10, 2026 | FELIMAZOLE 1.25 MG; FELIMAZOLE 2.5 MG; FELIMAZOLE 5 MG | Dechra Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| June 9, 2026 | DESFERAL | Mitem Pharma | New Drug Submission (NDS) · Admin |
| June 9, 2026 | APO-DAPAGLIFLOZIN-METFORMIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 9, 2026 | BUCCOLAM | Neuraxpharm Pharmaceuticals, S.L. | Supplement to a New Drug Submission (SNDS) · Other |
| June 9, 2026 | APO-ROSUVASTATIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 9, 2026 | SANDOZ TACROLIMUS | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 9, 2026 | APIXABAN | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 9, 2026 | NUCALA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 8, 2026 | PRO-LEVOCARB | Pro Doc Limitee | New Drug Submission (NDS) · Admin |
| June 8, 2026 | MOUNJARO; MOUNJARO KWIKPEN | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 8, 2026 | GABAPENTIN; PRO-GABAPENTIN | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| June 8, 2026 | IPG-PAROXETINE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 8, 2026 | NRA-ATENOLOL | Nora Pharma Inc. | New Drug Submission (NDS) · Admin |
| June 5, 2026 | TARO-TOFACITINIB; TARO-TOFACITINIB XR | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 5, 2026 | ESTRADIOL AND NORETHINDRONE ACETATE TABLETS | Novast Laboratories Ltd. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 5, 2026 | TEVA-NAPROXEN; TEVA-NAPROXEN EC | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 5, 2026 | ACH-IMATINIB | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 5, 2026 | FINASTERIDE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 5, 2026 | ZEPBOUND | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 5, 2026 | ACTIFEMME | Orb Pharma- Division Of Odan Laboratories Ltd. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 5, 2026 | INFANTS' IBUPROFEN ORAL SUSPENSION | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| June 5, 2026 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Priority |
| June 5, 2026 | APO-DOXY; APO-DOXY-TABS | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 5, 2026 | PRO-LISDEXAMFETAMINE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 4, 2026 | MINT-BILASTINE | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| June 4, 2026 | SLYND | Duchesnay Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 4, 2026 | BMD SOLUBLE | Phibro Animal Health Corporation | New Drug Submission (NDS) · Admin |
| June 3, 2026 | VASERETIC | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 3, 2026 | MINT-DONEPEZIL | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 3, 2026 | IDVYNSO | Merck Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| June 3, 2026 | ESTROGEL | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 2, 2026 | PRIORIX-TETRA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 2, 2026 | BOSULIF | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| June 2, 2026 | ATORVASTATIN | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 2, 2026 | JAMP NAPROXEN | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| June 2, 2026 | ERTAPENEM FOR INJECTION | Juno Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 1, 2026 | APO-LISDEXAMFETAMINE; APO-LISDEXAMFETAMINE CHEWABLE TABLETS | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 29, 2026 | SANDOZ LEFLUNOMIDE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 29, 2026 | TEVA-IMATINIB | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 29, 2026 | MAGNEVIST | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 29, 2026 | ACYCLOVIR | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 29, 2026 | FUCIBET | Leo Pharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 29, 2026 | PMS-DULOXETINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 29, 2026 | APO-LEVOTHYROXINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 29, 2026 | AA-MEDROXY | AA Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 29, 2026 | CAPECITABINE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 29, 2026 | OLANZAPINE FOR INJECTION | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| May 29, 2026 | PMS-VILAZODONE | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 29, 2026 | HYDRALAZINE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 29, 2026 | AG-DULOXETINE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 29, 2026 | NB-TAMSULOSIN CR | NB Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 29, 2026 | NRA-MONTELUKAST | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 29, 2026 | FLECAINIDE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 29, 2026 | EPTIFIBATIDE INJECTION | Juno Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 29, 2026 | LOARGYS | Immedica Pharma Ab | New Drug Submission (NDS) · Priority-NAS |
| May 29, 2026 | COSENTYX | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 29, 2026 | CONTINGENCY ONE | Senador Laboratories Private Limited | New Drug Submission (NDS) · Admin |
| May 28, 2026 | LYSODREN | Esteve Pharmaceuticals S.A. | Supplement to a New Drug Submission (SNDS) · Other |
| May 28, 2026 | AURO-BRIVARACETAM | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 28, 2026 | ACARBOSE TABLETS | Strides Pharma Canada Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| May 28, 2026 | IRINOTECAN HYDROCHLORIDE INJECTION | Eugia Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 28, 2026 | NOROMBY; NOROMBY HP | Juno Pharma Canada Inc. | New Drug Submission (NDS) · Admin |
| May 28, 2026 | ZYNYZ | Incyte Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| May 27, 2026 | TRUXIMA | Celltrion Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 27, 2026 | TARO-CAPECITABINE | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 27, 2026 | ELMARO | Elanco Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| May 27, 2026 | ACTOGAIN 100 | Phibro Animal Health Corporation | New Drug Submission (NDS) · Admin |
| May 26, 2026 | ALTA-PERINDOPRIL | Altamed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| May 26, 2026 | ALTA-AZITHROMYCIN | Altamed Pharma | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| May 26, 2026 | VORICONAZOLE FOR INJECTION | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 26, 2026 | NB-CANDESARTAN HCT | NB Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 26, 2026 | MYLAN-PANTOPRAZOLE T | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 26, 2026 | CIPROFLOXACIN INTRAVENOUS INFUSION BP; SANDOZ CIPROFLOXACIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 26, 2026 | AMIODARONE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 26, 2026 | APO-DULOXETINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 26, 2026 | TEVA-CLONIDINE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 26, 2026 | EXTRA STRENGTH IBUPROFEN LIQUID CAPSULES; IBUPROFEN LIQUID CAPSULES | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 26, 2026 | ENHERTU | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 25, 2026 | GABAPENTIN CAPSULES | Granules India Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 25, 2026 | BUPIVACAINE HYDROCHLORIDE INJECTION USP | Formative Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 25, 2026 | FLUOROURACIL INJECTION USP | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 25, 2026 | JAMP GUANFACINE XR | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 25, 2026 | KETOROLAC TROMETHAMINE INJECTION, USP | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 25, 2026 | EYLEA HD | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 25, 2026 | FAMOTIDINE TABLETS | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 22, 2026 | AREXVY | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 22, 2026 | RITUXAN SC | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 22, 2026 | DARZALEX | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 22, 2026 | SOGROYA | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 22, 2026 | ACT CIPROFLOXACIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 22, 2026 | MINT-ACITRETIN | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 22, 2026 | SUGAMMADEX INJECTION | Juno Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 22, 2026 | GABAPENTIN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 22, 2026 | DALACIN C PHOSPHATE | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| May 22, 2026 | YESAFILI | Biocon Biologics Canada Inc | New Drug Submission (NDS) · Admin |
| May 21, 2026 | YESINTEK; YESINTEK I.V. | Biocon Biologics Canada Inc | New Drug Submission (NDS) · Admin |
| May 21, 2026 | PANTOPRAZOLE SODIUM FOR INJECTION | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 21, 2026 | JAMP BICALUTAMIDE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 21, 2026 | AURO-CITALOPRAM | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 21, 2026 | PMS-ZOPICLONE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 21, 2026 | OCTAPLASMA | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| May 20, 2026 | RYALTRIS | Glenmark Specialty Sa | Supplement to a New Drug Submission (SNDS) · Other |
| May 20, 2026 | MINT-CAPECITABINE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 20, 2026 | VORANIGO | Servier Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 20, 2026 | M-MONTELUKAST | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 20, 2026 | METFORMIN | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| May 20, 2026 | RIVA-CELECOX | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 20, 2026 | R-PEN | Huvepharma Eood | Abbreviated New Drug Submission (ANDS) · Other |
| May 19, 2026 | OXALIPLATIN INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 19, 2026 | UPLIZNA | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 19, 2026 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 19, 2026 | APO-TAMOX | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 19, 2026 | PMS-SALBUTAMOL | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 19, 2026 | BIPAZEN | Kvr Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 18, 2026 | SPIKEVAX | Moderna Biopharma Canada Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| May 18, 2026 | STOBOCLO | Celltrion Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 18, 2026 | IXIFI | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| May 18, 2026 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 15, 2026 | NAT-IMATINIB | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 15, 2026 | APO-LEFLUNOMIDE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 15, 2026 | THYCONVI | BioSyent Pharma Inc. | New Drug Submission (NDS) · Other |
| May 15, 2026 | PMS-PROGESTERONE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 15, 2026 | JAMP IPRATROPIUM HFA | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 15, 2026 | JAMP LENALIDOMIDE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 15, 2026 | PENDO-CITALOPRAM | Pendopharm Division Of Pharmascience Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 15, 2026 | CELECOXIB | Alembic Pharmaceuticals Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 15, 2026 | TEVA-LETROZOLE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 15, 2026 | DULOXETINE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 15, 2026 | M-FINASTERIDE | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 15, 2026 | PMSC-ESOMEPRAZOLE DR | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 15, 2026 | IBUPROFEN LIQUID GEL | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 15, 2026 | OCREVUS | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 15, 2026 | L-S 20 | Phibro Animal Health Corporation | New Drug Submission (NDS) · Admin |
| May 15, 2026 | BRAVECTO QUANTUM | Intervet Canada Corp | Supplement to a New Drug Submission (SNDS) · Other |
| May 15, 2026 | AUREOMIX 625 G | Phibro Animal Health Corporation | New Drug Submission (NDS) · Admin |
| May 15, 2026 | SUDAFED SINUS ADVANCE | Kenvue Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 14, 2026 | IHEEZO | Apotex Inc. | New Drug Submission (NDS) · Other |
| May 14, 2026 | HEPCLUDEX | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 14, 2026 | PRO-ESOMEPRAZOLE | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| May 14, 2026 | METOPROLOL TARTRATE INJECTION USP | Juno Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 14, 2026 | JAMP TICAGRELOR | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 14, 2026 | ACH-TACROLIMUS | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 14, 2026 | APO-AMBRISENTAN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 14, 2026 | SANDOZ MYCOPHENOLATE MOFETIL | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 14, 2026 | MAR-DILTIAZEM CD | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 13, 2026 | ORKAMBI | Vertex Pharmaceuticals (Canada) Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| May 13, 2026 | SANDOZ FESOTERODINE FUMARATE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 13, 2026 | ELIGARD | Tolmar International Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| May 13, 2026 | ZDS-IVERMECTIN CREAM | Zydus Lifesciences Limited | Abbreviated New Drug Submission (ANDS) · Other |
| May 13, 2026 | MICRO I | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 13, 2026 | ETOPOSIDE INJECTION | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 13, 2026 | LIVTENCITY | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| May 13, 2026 | ORAP | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 13, 2026 | TEVA-AMIODARONE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 13, 2026 | TEVA-INDOMETHACIN | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 13, 2026 | MUSE | Knight Therapeutics Inc. | New Drug Submission (NDS) · Admin |
| May 13, 2026 | CARVYKTI | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 13, 2026 | PHESGO | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 13, 2026 | MVASI | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 12, 2026 | TERBINAFINE | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| May 12, 2026 | VANCOCIN | Searchlight Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 12, 2026 | NOVORAPID | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 12, 2026 | WAKIX | Knight Therapeutics Inc. | New Drug Submission (NDS) · Admin |
| May 12, 2026 | CAPECITABINE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 11, 2026 | SUPREFACT | Cheplapharm Arzneimittel Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| May 11, 2026 | JAMP NINTEDANIB | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 11, 2026 | TEVA-ZOPICLONE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 11, 2026 | CYCLOBENZAPRINE | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 11, 2026 | TECENTRIQ SC | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 11, 2026 | JAMP METHOTREXATE TABLETS | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 11, 2026 | PLOSBRIO | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Admin |
| May 8, 2026 | MICAFUNGIN FOR INJECTION, USP | Biocon Pharma Limited | Abbreviated New Drug Submission (ANDS) · Other |
| May 8, 2026 | APO-HYDROXYQUINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 8, 2026 | CAELYX | Baxter Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| May 8, 2026 | INCRELEX | Esteve Pharmaceuticals S.A. | New Drug Submission (NDS) · Admin |
| May 7, 2026 | PROPRANOLOL HYDROCHLORIDE INJECTION USP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 7, 2026 | NARCAN NASAL SPRAY | Emergent Operations Ireland Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 7, 2026 | ZIEXTENZO | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 7, 2026 | ZYNLONTA | Swedish Orphan Biovitrum Ab (Publ) | Supplement to a New Drug Submission (SNDS) · Other |
| May 7, 2026 | VYNDAMAX | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| May 7, 2026 | VYNDAQEL | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| May 7, 2026 | FILRA | JAMP Pharma Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| May 7, 2026 | BUSPIRONE TABLETS | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 7, 2026 | FUCIDIN CREAM 2%; FUCIDIN OINTMENT 2% | Leo Pharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 7, 2026 | TEVA-PROGESTERONE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 7, 2026 | ENZEEVU | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 7, 2026 | KISQALI | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 7, 2026 | CYTOGAM | Ki Biopharma Llc | Supplement to a New Drug Submission (SNDS) · Other |
| May 7, 2026 | PRO-FINASTERIDE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 7, 2026 | KIRSTY | Biocon Biologics Canada Inc | New Drug Submission (NDS) · Admin |
| May 7, 2026 | BEYFORTUS | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 7, 2026 | MYLAN-SUMATRIPTAN | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 7, 2026 | PMS-SUMATRIPTAN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 6, 2026 | JAMP DICLOFENAC FOR SOLUTION | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| May 6, 2026 | JAMP MIFEPRISTONE / MISOPROSTOL | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| May 6, 2026 | AURO-CEPHALEXIN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 6, 2026 | TEVA-PERINDOPRIL/INDAPAMIDE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 6, 2026 | JAMP DICLOFENAC FOR SOLUTION | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 5, 2026 | ROCURONIUM BROMIDE INJECTION | Juno Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 5, 2026 | ACARIZAX | Alk-Abello Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 5, 2026 | OCTREOTIDE DEPOT | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 5, 2026 | ZEPZELCA | Jazz Pharmaceuticals Ireland Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 5, 2026 | FUCIDIN H | Leo Pharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 5, 2026 | LENVIMA | Eisai Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 5, 2026 | FROVA | Knight Therapeutics Inc. | New Drug Submission (NDS) · Admin |
| May 5, 2026 | JAMP-DULOXETINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 5, 2026 | LAPELGA | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 5, 2026 | DATSCAN | Ge Healthcare Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 4, 2026 | VERAPAMIL HYDROCHLORIDE INJECTION USP | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 4, 2026 | NB-DONEPEZIL | NB Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 4, 2026 | MYRBETRIQ | Astellas Pharma Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 4, 2026 | VRAYLAR | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| May 1, 2026 | TRIKAFTA | Vertex Pharmaceuticals (Canada) Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| May 1, 2026 | JAMP APIXABAN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 1, 2026 | HEMABATE | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| May 1, 2026 | CAPECITABINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 1, 2026 | JAMP RIVAROXABAN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 1, 2026 | PRO-GABAPENTIN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 1, 2026 | BRUKINSA | Beone Medicines I Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| May 1, 2026 | NRA-DULOXETINE | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 1, 2026 | XYDALBA | Knight Therapeutics Inc. | New Drug Submission (NDS) · Admin |
| May 1, 2026 | DOXYTAB | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Admin |
| May 1, 2026 | GLICLAZIDE MR TABLETS | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 1, 2026 | TYENNE | Fresenius Kabi Canada Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| May 1, 2026 | PEXEGRA | JAMP Pharma Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| May 1, 2026 | IRBESARTAN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 1, 2026 | FLUOROURACIL INJECTION | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 1, 2026 | APO-SEMAGLUTIDE INJECTION | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| April 30, 2026 | LIBTAYO | Regeneron Canada Company | Supplement to a New Drug Submission (SNDS) · Other |
| April 30, 2026 | HIZENTRA | Csl Behring Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 30, 2026 | WEGOVY | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 30, 2026 | KISUNLA | Eli Lilly Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| April 30, 2026 | FABHALTA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 30, 2026 | TEVA-SALBUTAMOL HFA | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 30, 2026 | SOTYKTU | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| April 30, 2026 | DEPAKENE | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| April 30, 2026 | EPIVAL | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| April 30, 2026 | EUGIA-NINTEDANIB | Eugia Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 29, 2026 | VOLTAREN RAPIDE | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 29, 2026 | VOLTAREN | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 29, 2026 | AURO-BOSENTAN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 29, 2026 | METROGEL | Galderma Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 29, 2026 | ATORVASTATIN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 29, 2026 | CINACALCET | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| April 29, 2026 | SANDOZ DOLUTEGRAVIR | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 29, 2026 | SANDOZ DOLUTEGRAVIR | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 29, 2026 | SANDOZ DOLUTEGRAVIR | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 29, 2026 | SANDOZ DOLUTEGRAVIR | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 29, 2026 | SANDOZ DOLUTEGRAVIR | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 29, 2026 | SANDOZ DOLUTEGRAVIR | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 29, 2026 | SANDOZ DOLUTEGRAVIR | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| April 29, 2026 | NRA-CELECOXIB | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 28, 2026 | BEVQOLVA | Curateq Biologics Private Limited | New Drug Submission (NDS) · Other |
| April 28, 2026 | VENCLEXTA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| April 28, 2026 | DIACOMIT | Biocodex Sas | Supplement to a New Drug Submission (SNDS) · Other |
| April 28, 2026 | SEMAGLUTIDE INJECTION | Dr Reddys Laboratories Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| April 28, 2026 | RIVA-DICLOFENAC | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| April 28, 2026 | RIVA-DICLOFENAC | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 27, 2026 | GAMMAGARD S/D | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| April 27, 2026 | HYQVIA | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| April 27, 2026 | FLUCELVAX | Seqirus Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 27, 2026 | PRIORIX-TETRA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 27, 2026 | PRIORIX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 27, 2026 | GABAPENTIN | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 27, 2026 | BEYFORTUS | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 27, 2026 | SANDOZ RIVAROXABAN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 27, 2026 | BIO-AZITHROMYCIN | Biomed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| April 27, 2026 | PROTOPIC | Leo Pharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 27, 2026 | CASPOFUNGIN FOR INJECTION | Juno Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| April 27, 2026 | PMS-GABAPENTIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 24, 2026 | OMVOH | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 24, 2026 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Priority |
| April 24, 2026 | PMS-TOFACITINIB | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 24, 2026 | RIVA-HYDROXYUREA | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 24, 2026 | EPIRUBICIN HYDROCHLORIDE INJECTION | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 24, 2026 | PRIMOVIST | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 24, 2026 | JAMP CANDESARTAN-HCT | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 24, 2026 | METFORMIN ER | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 23, 2026 | JAMP INDAPAMIDE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| April 23, 2026 | CITALOPRAM | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 23, 2026 | TEVA-PROGESTERONE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 23, 2026 | VFEND | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| April 23, 2026 | CEFAZOLIN IN DEXTROSE INJECTION, USP | Baxter Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 23, 2026 | ORTHOXICAM | Modern Veterinary Therapeutics Llc | Abbreviated New Drug Submission (ANDS) · Other |
| April 23, 2026 | M-RIVAROXABAN | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 23, 2026 | AG-LAMOTRIGINE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 22, 2026 | BEKEMV | Amgen Canada Inc | New Drug Submission (NDS) · Other |
| April 22, 2026 | EVRYSDI | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 22, 2026 | APO-DICLOFENAC POWDER | Apotex Inc. | New Drug Submission (NDS) · Admin |
| April 22, 2026 | QULIPTA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| April 22, 2026 | M-BILASTINE | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 22, 2026 | FLUVIRAL | Id Biomedical Corporation Of Quebec | Supplement to a New Drug Submission (SNDS) · Other |
| April 22, 2026 | ACTEMRA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 21, 2026 | AURO-FLECAINIDE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 21, 2026 | NB-IRBESARTAN | NB Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 21, 2026 | ZEJULA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 21, 2026 | BIVALIRUDIN INJECTION | Avir Pharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 21, 2026 | ZENHALE | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 21, 2026 | REMODULIN | United Therapeutics Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| April 21, 2026 | ENSTILAR | Leo Pharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 21, 2026 | REVATIO | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| April 21, 2026 | BRAVECTO | Intervet Canada Corp | Supplement to a New Drug Submission (SNDS) · Other |
| April 20, 2026 | KAVIGALE | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 20, 2026 | PEGASYS | Pharmaand Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| April 20, 2026 | ABRYSVO | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| April 20, 2026 | NORDITROPIN | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 20, 2026 | AYVAKYT | Blueprint Medicines Corporation | Supplement to a New Drug Submission (SNDS) · Priority |
| April 20, 2026 | ROZLYTREK | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 20, 2026 | TARO-LISDEXAMFETAMINE; TARO-LISDEXAMFETAMINE CHEWABLE TABLETS | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 20, 2026 | VEREGEN | Knight Therapeutics Inc. | New Drug Submission (NDS) · Admin |
| April 20, 2026 | ELFY | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| April 20, 2026 | OCTAGAM; OCTAGAM 5% | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| April 20, 2026 | LUPIN-LETERMOVIR | Lupin Pharma Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| April 20, 2026 | TECENTRIQ; TECENTRIQ SC | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 20, 2026 | IPG-ZOPICLONE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 18, 2026 | CONEXXENCE | Fresenius Kabi Canada Ltd | New Drug Submission (NDS) · Other |
| April 18, 2026 | BOMYNTRA | Fresenius Kabi Canada Ltd | New Drug Submission (NDS) · Other |
| April 17, 2026 | VEVZUO | Biosimilar Collaborations Ireland Limited | New Drug Submission (NDS) · Other |
| April 17, 2026 | BOSAYA | Biosimilar Collaborations Ireland Limited | New Drug Submission (NDS) · Other |
| April 17, 2026 | RENVELA | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 17, 2026 | TOBI | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| April 17, 2026 | AG-AMOXICILLIN | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 17, 2026 | TRINTELLIX | Lundbeck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 17, 2026 | REACTINE 20 MG TABLET | Kenvue Canada Inc. | New Drug Submission (NDS) · Admin |
| April 17, 2026 | AG-GABAPENTIN | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 17, 2026 | ACH-HYDROXYCHLOROQUINE SULFATE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 17, 2026 | MINT-IMATINIB | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 17, 2026 | TEVA-MEDROXYPROGESTERONE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 17, 2026 | OZURDEX | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| April 17, 2026 | JAMP LISDEXAMFETAMINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 17, 2026 | JAMP SUMATRIPTAN DF | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 17, 2026 | APO-ZOPICLONE | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 17, 2026 | TEVA-CITALOPRAM | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 17, 2026 | ACID CONTROLLER MAXIMUM STRENGTH | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 17, 2026 | VITRECTO | Intervet Canada Corp | Supplement to a New Drug Submission (SNDS) · Other |
| April 17, 2026 | MAR-MONTELUKAST | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 17, 2026 | MINJUVI | Incyte Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| April 16, 2026 | TEVIMBRA | Beone Medicines I Gmbh | New Drug Submission (NDS) · Other |
| April 16, 2026 | NURTEC ODT | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| April 16, 2026 | PENTASA | Ferring Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 16, 2026 | NAT-BOSENTAN | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 15, 2026 | STEQEYMA; STEQEYMA I.V. | Celltrion Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 15, 2026 | TARO-DICLOFENAC POTASSIUM POWDER FOR ORAL SOLUTION | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| April 15, 2026 | PMS-IRBESARTAN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 15, 2026 | INOMAX | Ino Therapeutics | Supplement to a New Drug Submission (SNDS) · Other |
| April 15, 2026 | JAMP DIVALPROEX | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 15, 2026 | JAMP SPIRONOLACTONE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 15, 2026 | PRO-OLANZAPINE ODT | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 15, 2026 | CREDELIO QUATTRO | Elanco Canada Limited | New Drug Submission (NDS) · Other |
| April 14, 2026 | PMS-DOLUTEGRAVIR | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| April 14, 2026 | PMS-DOLUTEGRAVIR | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 14, 2026 | ACH-CAPECITABINE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 14, 2026 | APO-CAPECITABINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 14, 2026 | VYALEV | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| April 14, 2026 | TEVA-APIXABAN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 14, 2026 | OZEMPIC | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 13, 2026 | OBODENCE | Samsung Bioepis Co., Ltd | New Drug Submission (NDS) · Other |
| April 13, 2026 | NURTEC ODT | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| April 13, 2026 | MAR-CELECOXIB | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 13, 2026 | APO-APIXABAN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 13, 2026 | BIO-VENLAFAXINE XR | Biomed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| April 13, 2026 | ATENOLOL TABLETS | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| April 10, 2026 | LUNSUMIO SC | Hoffmann-La Roche Limited | New Drug Submission (NDS) · Other |
| April 10, 2026 | TEVA-LORAZEPAM | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 10, 2026 | ZYPREXA ZYDIS | Cheplapharm Registration Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| April 10, 2026 | ZYVOXAM | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| April 10, 2026 | BIO-QUETIAPINE | Biomed Pharma | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 10, 2026 | UPGOLYV | JAMP Pharma Corporation | New Drug Submission (NDS) · Other |
| April 10, 2026 | VUEWAY | Bracco Imaging Canada | New Drug Submission (NDS) · New Active Substance (NAS) |
| April 10, 2026 | NAT-SUNITINIB | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 10, 2026 | OTEZLA | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 10, 2026 | VOLTAREN EMULGEL; VOLTAREN EMULGEL ACTIVE; VOLTAREN EMULGEL BACK & MUSCLE PAIN; VOLTAREN EMULGEL JOINT PAIN REGULAR STRENGTH | Haleon Canada ULC | Supplement to a New Drug Submission (SNDS) · Other |
| April 10, 2026 | ROPIVACAINE HYDROCHLORIDE INJECTION, USP | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 10, 2026 | PRO-APIXABAN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 10, 2026 | ASA 81 MG | Laboratoires Trianon Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 9, 2026 | NB-CIPROFLOXACIN | NB Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| April 9, 2026 | NEFFY | Alk-Abello Inc | New Drug Submission (NDS) · Other |
| April 9, 2026 | XELJANZ; XELJANZ XR | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| April 9, 2026 | TABRECTA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 9, 2026 | SANDOZ CAPECITABINE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 9, 2026 | IBSRELA | Knight Therapeutics Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 9, 2026 | TEVA-DILTIAZEM T | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 9, 2026 | CELECOXIB | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 9, 2026 | JAMP-OMEPRAZOLE DR | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 9, 2026 | YEYTUO | Gilead Sciences Canada Inc | New Drug Submission (NDS) · Other |
| April 9, 2026 | IBUPROFEN CAPLETS 200 MG; IBUPROFEN TABLETS 200 MG | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 9, 2026 | ATENOLOL TABLETS | Sanis Health Inc. | New Drug Submission (NDS) · Admin |
| April 9, 2026 | CREDELIO PLUS | Elanco Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 9, 2026 | PAIN RELIEF GEL EXTRA STRENGTH | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 8, 2026 | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Jubilant Generics Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 8, 2026 | JAMP BIMATOPROST | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| April 8, 2026 | LEVETIRACETAM INJECTION USP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 8, 2026 | EMPAVELI | Swedish Orphan Biovitrum Ab (Publ) | Supplement to a New Drug Submission (SNDS) · Priority |
| April 8, 2026 | APO-BISOPROLOL | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 8, 2026 | MINT-SPIRONOLACTONE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 8, 2026 | NB-ATORVASTATIN | NB Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 8, 2026 | METFORMIN XR | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| April 8, 2026 | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | Eugia Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 8, 2026 | TARO-WARFARIN | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 8, 2026 | ANTIZOL | Knight Therapeutics Inc. | New Drug Submission (NDS) · Admin |
| April 7, 2026 | INLYTA | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| April 7, 2026 | REBLOZYL | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| April 7, 2026 | SIMPONI; SIMPONI I.V. | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 7, 2026 | ALENDRONATE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 7, 2026 | SYNFLORIX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 7, 2026 | TARO-METRONIDAZOLE GEL | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| April 7, 2026 | KISQALI | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 7, 2026 | GLUCOPHAGE | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 2, 2026 | MEN'S GLN-MINOXIDIL | Glenmark Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 2, 2026 | JAMP MINOXIDIL SOLUTION | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 2, 2026 | WOMEN'S GLN-MINOXIDIL | Glenmark Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 2, 2026 | UTROGESTAN | Besins Healthcare S A | Supplement to a New Drug Submission (SNDS) · Other |
| April 2, 2026 | ZEPBOUND | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 2, 2026 | MOUNJARO; MOUNJARO KWIKPEN | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 2, 2026 | APO-POMALIDOMIDE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 2, 2026 | PONSTAN | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 2, 2026 | LYNPARZA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 2, 2026 | BIO-DIENOGEST | Biomed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| April 2, 2026 | ACYCLOVIR SODIUM INJECTION | Eugia Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 1, 2026 | PRZ-SPIRONOLACTONE | Pharmaris Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| April 1, 2026 | TARO-IMIQUIMOD; TARO-IMIQUIMOD PUMP | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 1, 2026 | WIXELA INHUB | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 1, 2026 | ACH-PRAVASTATIN | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 1, 2026 | XIGDUO | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 1, 2026 | KOMBOGLYZE | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 1, 2026 | KAZANO | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| April 1, 2026 | MONUROL | Knight Therapeutics Inc. | New Drug Submission (NDS) · Admin |
| April 1, 2026 | ROTATEQ | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 1, 2026 | PMS-CITALOPRAM | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 1, 2026 | DIVALPROEX | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 1, 2026 | SUMATRIPTAN INJECTION, USP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 1, 2026 | APO-IMATINIB | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 1, 2026 | TARO-DEFERIPRONE | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 1, 2026 | MINT-CELECOXIB | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 1, 2026 | NATCO-CITALOPRAM | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 1, 2026 | RIVASA 81 MG EC | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 1, 2026 | JAMP ZOPICLONE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 1, 2026 | CITALOPRAM | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 1, 2026 | MINT-CITALOPRAM | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 31, 2026 | WINREVAIR | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 31, 2026 | NATESTO | Acerus Biopharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 31, 2026 | RYSTIGGO | Ucb Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 31, 2026 | SHINGRIX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 31, 2026 | CAMCEVI | Accord Healthcare Inc | New Drug Submission (NDS) · Other |
| March 31, 2026 | DOMPERIDONE TABLETS | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| March 31, 2026 | RIASTAP | Csl Behring Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 30, 2026 | XBRYK | Samsung Bioepis Co., Ltd | New Drug Submission (NDS) · Other |
| March 30, 2026 | IRBESARTAN | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 30, 2026 | MRESVIA | Moderna Biopharma Canada Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| March 30, 2026 | RIVA-CINACALCET | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 30, 2026 | AG-GUANFACINE XR | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 30, 2026 | JAMP GABAPENTIN TABLETS | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 30, 2026 | ACH-PROGESTERONE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 30, 2026 | AURO-ENZALUTAMIDE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 30, 2026 | AURO-ENZALUTAMIDE | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 30, 2026 | AURO-ENZALUTAMIDE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 30, 2026 | AURO-ENZALUTAMIDE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 30, 2026 | AURO-ENZALUTAMIDE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 30, 2026 | APO-ENZALUTAMIDE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 30, 2026 | AURO-ENZALUTAMIDE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 30, 2026 | APO-ENZALUTAMIDE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 30, 2026 | REDDY-ENZALUTAMIDE | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 30, 2026 | AURO-ENZALUTAMIDE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 30, 2026 | REDDY-ENZALUTAMIDE | Dr Reddys Laboratories Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| March 30, 2026 | VOLTAREN EMULGEL EXTRA STRENGTH; VOLTAREN EMULGEL JOINT PAIN EXTRA STRENGTH | Haleon Canada ULC | Supplement to a New Drug Submission (SNDS) · Other |
| March 27, 2026 | APO-HYDROXYUREA | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 27, 2026 | JAMP TOFACITINIB | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 27, 2026 | MINT-HYDROXYCHLOROQUINE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 27, 2026 | TEVA-LISDEXAMFETAMINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 27, 2026 | SUMATRIPTAN INJECTION, USP | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 27, 2026 | APO-GUANFACINE XR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 27, 2026 | JAMP VALPROIC ACID ORAL SOLUTION | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 27, 2026 | TEPADINA | Adienne Sa | Supplement to a New Drug Submission (SNDS) · Other |
| March 27, 2026 | SUGAMMADEX | Avir Pharma Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 27, 2026 | APO-AMPHETAMINE XR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 26, 2026 | MENQUADFI | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 26, 2026 | SPEVIGO | Leo Pharma Inc | New Drug Submission (NDS) · Admin |
| March 26, 2026 | PRO-DILTIAZEM CD | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Admin |
| March 26, 2026 | JAMP HYDROXYCHLOROQUINE SULFATE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 26, 2026 | ADTRALZA | Leo Pharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 26, 2026 | BREVICON 0.5/35 TABLETS (21 DAY PACK); BREVICON 0.5/35 TABLETS (28 DAY PACK); BREVICON 1/35 TABLETS (21 DAY PACK); BREVICON 1/35 TABLETS (28 DAY PACK) | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 26, 2026 | RIVA-CARVEDILOL | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 26, 2026 | CTP 30 | Knight Therapeutics Inc. | New Drug Submission (NDS) · Admin |
| March 26, 2026 | LEFLUNOMIDE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 25, 2026 | MUSCLE AND BACK PAIN PLATINUM RELIEF | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 25, 2026 | DONEPEZIL HYDROCHLORIDE | Jubilant Generics Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 25, 2026 | BURINEX | Karo Pharma Ab | Supplement to a New Drug Submission (SNDS) · Other |
| March 25, 2026 | DALACIN C FLAVOURED GRANULES | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 25, 2026 | VANFLYTA | Daiichi Sankyo Pharma Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 25, 2026 | TOPIRAMATE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 25, 2026 | JAMP SUMATRIPTAN / NAPROXEN SODIUM | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| March 25, 2026 | AURO-ELETRIPTAN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 25, 2026 | TARO-TESTOSTERONE GEL (2.5G/PACKET); TARO-TESTOSTERONE GEL (5G/PACKET) | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 25, 2026 | OCTREOTIDE INJECTION | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 25, 2026 | LAZCLUZE | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 25, 2026 | SERC | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| March 25, 2026 | POLIVY | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 25, 2026 | LEVOCARNITINE INJECTION | Juno Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 25, 2026 | MINT-DOXYCYCLINE | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| March 24, 2026 | ADHEROZA | Accord Healthcare Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 24, 2026 | PAXLOVID | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 24, 2026 | LOKELMA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 24, 2026 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| March 24, 2026 | FLORINEF | Knight Therapeutics Inc. | New Drug Submission (NDS) · Admin |
| March 24, 2026 | SANDOZ TACROLIMUS XR | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 24, 2026 | MIRAPEX | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| March 23, 2026 | MENOPUR | Ferring Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 23, 2026 | BAVENCIO | Emd Serono A Division Of Emd Inc Canada | Supplement to a New Drug Submission (SNDS) · Other |
| March 23, 2026 | METFORMIN TABLETS | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 23, 2026 | ENVARSUS PA | Knight Therapeutics Inc. | New Drug Submission (NDS) · Admin |
| March 23, 2026 | M-ESCITALOPRAM | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 23, 2026 | DENOZA | Apotex Inc. | New Drug Submission (NDS) · Other |
| March 23, 2026 | LIBTAYO | Regeneron Canada Company | Supplement to a New Drug Submission (SNDS) · Other |
| March 23, 2026 | TREMFYA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 20, 2026 | GONAL-F PEN | Emd Serono A Division Of Emd Inc Canada | Supplement to a New Drug Submission (SNDS) · Other |
| March 20, 2026 | ZYPREXA; ZYPREXA INTRAMUSCULAR | Cheplapharm Registration Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| March 20, 2026 | QUVIVIQ | Idorsia Pharmaceuticals Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| March 20, 2026 | OJJAARA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 20, 2026 | METADOL | Knight Therapeutics Inc. | New Drug Submission (NDS) · Admin |
| March 20, 2026 | AG-ATORVASTATIN | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 20, 2026 | PRO-SERTRALINE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 20, 2026 | JAMP COLESEVELAM | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| March 20, 2026 | RIVA-SIMVASTATIN | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 20, 2026 | BRIDION | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 20, 2026 | MINT-FUROSEMIDE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 20, 2026 | ADVAIR DISKUS | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 20, 2026 | PRO-IRBESARTAN-HCTZ | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 20, 2026 | ACT CITALOPRAM | Knight Therapeutics Inc. | New Drug Submission (NDS) · Admin |
| March 20, 2026 | SALBUTAMOL HFA | Sanis Health Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| March 19, 2026 | ERLEADA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 19, 2026 | ZERBAXA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 19, 2026 | TARO-MELPHALAN | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 18, 2026 | SANDOZ SILODOSIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 18, 2026 | ODAN-ARIPIPRAZOLE SOLUTION | Odan Laboratories Ltd. | New Drug Submission (NDS) · Other |
| March 18, 2026 | AURO-TOFACITINIB | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 18, 2026 | SANDOZ ESTRADIOL DERM 100; SANDOZ ESTRADIOL DERM 50; SANDOZ ESTRADIOL DERM 75 | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 18, 2026 | GALAFOLD | Amicus Therapeutics Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 18, 2026 | TEVA-ABACAVIR/LAMIVUDINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 18, 2026 | JAMP ENZALUTAMIDE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 18, 2026 | HYDROCHLOROTHIAZIDE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 17, 2026 | ENSPRYNG | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 17, 2026 | M-M-R II | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 17, 2026 | DACARBAZINE FOR INJECTION | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 17, 2026 | MALARONE; MALARONE PEDIATRIC | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 17, 2026 | MYLAN-HYDROXYUREA | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 16, 2026 | CNJ-016 | Emergent Biosolutions Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 16, 2026 | ADSTILADRIN | Ferring Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| March 16, 2026 | BLENREP | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 16, 2026 | TOUJEO DOUBLESTAR | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 16, 2026 | BORTEZOMIB INJECTION | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 16, 2026 | UROMITEXAN | Baxter Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| March 16, 2026 | SANDOZ BIMATOPROST RC | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 16, 2026 | BIMATOPROST RC | Juno Pharmaceuticals Corp. | Abbreviated New Drug Submission (ANDS) · Other |
| March 16, 2026 | APO-BIMATOPROST RC | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 16, 2026 | SANDOZ BIMATOPROST | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 16, 2026 | SANDOZ BIMATOPROST RC | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| March 16, 2026 | JAMP BIMATOPROST SOLUTION RC | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| March 16, 2026 | APO-BIMATOPROST RC | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 16, 2026 | BIMATOPROST RC | Juno Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 16, 2026 | PRO-BIMATOPROST RC | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| March 16, 2026 | SPC-ESCITALOPRAM | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 13, 2026 | KEPPRA | Ucb Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 13, 2026 | CLOBIVIS | Apotex Inc. | New Drug Submission (NDS) · Other |
| March 13, 2026 | STEQEYMA; STEQEYMA I.V. | Celltrion Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 13, 2026 | PLENDIL | Glenwood Gmbh Pharmazeutische Erzeugnisse | Supplement to a New Drug Submission (SNDS) · Other |
| March 13, 2026 | TEVA-ROSUVASTATIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 13, 2026 | IPG-TOPIRAMATE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 13, 2026 | VALTREX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 13, 2026 | AG-ALENDRONATE SODIUM | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 13, 2026 | MOMETAMAX SINGLE | Intervet Canada Corp | New Drug Submission (NDS) · Other |
| March 13, 2026 | PROPOFOL INJECTION | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 12, 2026 | ZIMED PF | Luvo Medical Technologies, Inc. | New Drug Submission (NDS) · Admin |
| March 12, 2026 | JAMP CELECOXIB | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 12, 2026 | KISQALI | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 12, 2026 | APO-NILOTINIB | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 12, 2026 | LIPIODOL ULTRA FLUID | Guerbet | Supplement to a New Drug Submission (SNDS) · Other |
| March 12, 2026 | JAMP-GABAPENTIN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 12, 2026 | DILTIAZEM CD | Sivem Pharmaceuticals Ulc | Supplement to a New Drug Submission (SNDS) · Admin |
| March 12, 2026 | REACTINE; REACTINE ALLERGY; REACTINE ALLERGY LIQUID GELS; REACTINE FAST MELT JUNIOR; REACTINE RAPID DISSOLVE | Kenvue Canada Inc. | New Drug Submission (NDS) · Admin |
| March 12, 2026 | REACTINE COMPLETE | Kenvue Canada Inc. | New Drug Submission (NDS) · Admin |
| March 12, 2026 | IMODIUM CALMING LIQUID; IMODIUM LIQUI-GELS; IMODIUM QUICK DISSOLVE | Kenvue Canada Inc. | New Drug Submission (NDS) · Admin |
| March 11, 2026 | IDENOS | Apotex Inc. | New Drug Submission (NDS) · Other |
| March 11, 2026 | DEPO-PROVERA | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 11, 2026 | ONUREG | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| March 11, 2026 | JAMP PRAVASTATIN TABLETS | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 11, 2026 | SPC-EZETIMIBE | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 11, 2026 | GABAPENTIN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 10, 2026 | LACOSAMIDE | Jubilant Generics Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 10, 2026 | PMS-DEXTROAMPHETAMINE | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 10, 2026 | PRO-BICALUTAMIDE | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| March 10, 2026 | PRO-MOMETASONE | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| March 10, 2026 | DOBUTAMINE INJECTION USP | Hikma Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 9, 2026 | PREVNAR 20 | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 9, 2026 | TUZEMTY | Shanghai Henlius Biotech, Inc. | New Drug Submission (NDS) · Other |
| March 9, 2026 | BILDYOS | Shanghai Henlius Biotech, Inc. | New Drug Submission (NDS) · Other |
| March 9, 2026 | WELLBUTRIN XL | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 9, 2026 | RHINOCORT AQUA | Kenvue Canada Inc. | New Drug Submission (NDS) · Admin |
| March 9, 2026 | GEN-CLOZAPINE | Mylan Pharmaceuticals Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 9, 2026 | AMOXICILLIN CAPSULES BP | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 9, 2026 | TRIDURAL | Knight Therapeutics Inc. | New Drug Submission (NDS) · Admin |
| March 9, 2026 | AG-ANASTROZOLE TABLETS | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 9, 2026 | NUMELVI | Intervet Canada Corp | New Drug Submission (NDS) · Other |
| March 6, 2026 | NUVAXOVID | Sanofi Vaccines Canada Ltd. | New Drug Submission (NDS) · Admin |
| March 6, 2026 | JUBLIA | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 6, 2026 | SKYCLARYS | Biogen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 6, 2026 | CYSKLAR | Leadiant Biosciences, Inc. | New Drug Submission (NDS) · Other |
| March 6, 2026 | DEFERASIROX (TYPE J) | Jubilant Generics Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 6, 2026 | NUCYNTA IR | Knight Therapeutics Inc. | New Drug Submission (NDS) · Admin |
| March 6, 2026 | RIVA-CANDESARTAN | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 6, 2026 | JAMP IRBESARTAN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 6, 2026 | RADICAVA | Tanabe Pharma Corporation | New Drug Submission (NDS) · Admin |
| March 6, 2026 | PRAXIS ASA EC 81 MG DAILY LOW DOSE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 5, 2026 | DUPIXENT | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 5, 2026 | OLMESARTAN MEDOXOMIL / HYDROCHLOROTHIAZIDE | Jubilant Generics Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 5, 2026 | AURO-CLADRIBINE | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 5, 2026 | APO-AMOXICILLIN | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 5, 2026 | MEPRON | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 5, 2026 | NUCYNTA EXTENDED-RELEASE | Knight Therapeutics Inc. | New Drug Submission (NDS) · Admin |
| March 5, 2026 | METADOL-D | Knight Therapeutics Inc. | New Drug Submission (NDS) · Admin |
| March 5, 2026 | IRBESARTAN HCT | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 5, 2026 | APO-AMOXI | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 5, 2026 | SAPHNELO | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 5, 2026 | AURO-PROGESTERONE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 5, 2026 | M-VENLAFAXINE XR | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 5, 2026 | AG-EDOXABAN | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 4, 2026 | AURO-IRBESARTAN HCT | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 4, 2026 | QULIPTA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| March 4, 2026 | BALANSYA | Orimed Pharma Inc. | New Drug Submission (NDS) · Other |
| March 4, 2026 | IPG-EZETIMIBE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 4, 2026 | FINACEA | Leo Pharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 4, 2026 | NRA-RIVAROXABAN TABLETS | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 4, 2026 | TENOFOVIR | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| March 4, 2026 | COMPUDOSE | Elanco Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 3, 2026 | RBX-ATORVASTATIN | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 3, 2026 | ETOPOSIDE INJECTION | Hikma Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 3, 2026 | BLEOMYCIN FOR INJECTION | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 3, 2026 | PRO-SITAGLIPTIN-METFORMIN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 3, 2026 | NB-MONTELUKAST | NB Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| March 3, 2026 | APO-SORAFENIB | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 3, 2026 | ATORVASTATIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 3, 2026 | INVOKAMET | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 3, 2026 | LAMOTRIGINE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 3, 2026 | NRA-SITAGLIPTIN/METFORMIN | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 3, 2026 | APO-TRYPTOPHAN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 3, 2026 | REDDY-PROGESTERONE | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 3, 2026 | SUGAMMADEX INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 3, 2026 | EUGIA-METHOTREXATE | Eugia Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 3, 2026 | LAMOTRIGINE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 2, 2026 | TAKHZYRO | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| March 2, 2026 | PRIORIX-TETRA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 2, 2026 | VARILRIX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 1, 2026 | MOTRIN 200MG; MOTRIN 300MG; MOTRIN 400MG | Kenvue Canada Inc. | New Drug Submission (NDS) · Admin |
| February 27, 2026 | RIVA-DAPAGLIFLOZIN | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 27, 2026 | DRAX EXAMETAZIME | Jubilant Draximage Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 27, 2026 | BLINCYTO | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 27, 2026 | NEXPLANON | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 27, 2026 | LORAZEPAM INJECTION, USP | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 27, 2026 | JAMP POMALIDOMIDE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 27, 2026 | APO-DASATINIB | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 27, 2026 | JAMP TOPIRAMATE TABLETS | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 27, 2026 | EUGIA-HYDROXYUREA | Eugia Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 27, 2026 | ACETYLCYSTEINE SOLUTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 27, 2026 | TEVA-DEXTROAMPHETAMINE SR | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 27, 2026 | NEXIUM | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 27, 2026 | GLN-TOPIRAMATE | Glenmark Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 27, 2026 | AURO-DEFERASIROX (TYPE J) | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 26, 2026 | ENTRESTO | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 26, 2026 | RIVA APIXABAN | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 26, 2026 | CONVENIA RTU | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 26, 2026 | LABETALOL HYDROCHLORIDE INJECTION USP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 26, 2026 | CHILDREN'S MOTRIN; CHILDREN’S MOTRIN CHEWABLE TABLETS; INFANTS' MOTRIN; JUNIOR STRENGTH MOTRIN CHEWABLE TABLETS | Kenvue Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 26, 2026 | MOTRIN LIQUID GELS 200MG; MOTRIN LIQUID GELS 400 MG | Kenvue Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 26, 2026 | MOTRIN PLATINUM MUSCLE & BODY | Kenvue Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 26, 2026 | EXTRA STRENGTH TYLENOL NIGHTTIME | Kenvue Canada Inc. | New Drug Submission (NDS) · Admin |
| February 26, 2026 | MEKTOVI | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 26, 2026 | DEXMEDESED | Dechra Veterinary Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 26, 2026 | ADVIL COLD & SINUS CONVENIENCE PACK | Haleon Canada ULC | New Drug Submission (NDS) · Admin |
| February 25, 2026 | ACH-RIVAROXABAN | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 25, 2026 | APO-DILTIAZ CD | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 25, 2026 | MAR-DILTIAZEM CD | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 25, 2026 | OZEMPIC | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 25, 2026 | KOSELUGO | Alexion Pharma Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| February 25, 2026 | OKEDI | Laboratorios Farmaceuticos Rovi, S.A. | Supplement to a New Drug Submission (SNDS) · Other |
| February 25, 2026 | LONGAVO | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 25, 2026 | LOSARTAN POTASSIUM | Jubilant Generics Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 25, 2026 | AZACITIDINE FOR INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 25, 2026 | PMS-BOSENTAN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 25, 2026 | PMS-RIVAROXABAN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 25, 2026 | APO-ATORVASTATIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 25, 2026 | NRA-ATENOLOL | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 25, 2026 | M-ZOLMITRIPTAN | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 25, 2026 | NB-PRAMIPEXOLE | NB Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 25, 2026 | TEVA-PERINDOPRIL | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 25, 2026 | MINT-CITALOPRAM SOLUTION | Mint Pharmaceuticals Inc | New Drug Submission (NDS) · Other |
| February 25, 2026 | DEXEDRINE; DEXEDRINE SPANSULE | Knight Therapeutics Inc. | New Drug Submission (NDS) · Admin |
| February 25, 2026 | NRA-SITAGLIPTIN TABLETS | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 24, 2026 | GRASTOFIL | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 24, 2026 | TEVA-IRBESARTAN HCTZ | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 24, 2026 | M-DILTIAZEM T | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 24, 2026 | NB-CANDESARTAN | NB Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 24, 2026 | NRA-DIENOGEST | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 24, 2026 | SUGAMMADEX INJECTION | Juno Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 24, 2026 | NRA-RISPERIDONE | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 24, 2026 | BORTEZOMIB FOR INJECTION | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 24, 2026 | SUGAMMADEX INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 23, 2026 | APO-LISDEXAMFETAMINE CAPSULES | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 23, 2026 | TEVA-AMPHETAMINE XR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 23, 2026 | PRIORIX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 23, 2026 | PMS-VALPROIC ACID; PMS-VALPROIC ACID E.C. | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 23, 2026 | SUGAMMADEX INJECTION | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 23, 2026 | ESOMEPRAZOLE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 20, 2026 | ENDOMETRIN | Ferring Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 20, 2026 | QUADRACEL | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 20, 2026 | PENTACEL | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 20, 2026 | LEUCOVORIN CALCIUM INJECTION USP | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| February 20, 2026 | IMFINZI | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 20, 2026 | SILODOSIN | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 20, 2026 | NRA-BICALUTAMIDE | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 20, 2026 | APO-DASATINIB | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 20, 2026 | AURO-AZILSARTAN MEDOXOMIL | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 20, 2026 | EXTRA STRENGTH ALLERGY RELIEF; REGULAR STRENGTH ALLERGY RELIEF | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 20, 2026 | MYLAN-DIVALPROEX | Mylan Pharmaceuticals Ulc | Supplement to a New Drug Submission (SNDS) · Admin |
| February 20, 2026 | FLUDARABINE PHOSPHATE FOR INJECTION | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 20, 2026 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP; DEXMEDETOMIDINE HYDROCHLORIDE INJECTION | Juno Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 19, 2026 | NUVAXOVID | Novavax Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 19, 2026 | PMS-IRBESARTAN-HCTZ | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 19, 2026 | ARAVA | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 19, 2026 | AURO-TOPIRAMATE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 18, 2026 | COMIRNATY | Biontech Manufacturing Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| February 18, 2026 | MIDAZOLAM INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 18, 2026 | WOMEN'S HAIR REGROWTH TREATMENT | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 18, 2026 | TEVA-ESCITALOPRAM | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 18, 2026 | AVAPRO | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 18, 2026 | REDDY-POMALIDOMIDE | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 18, 2026 | LUMAKRAS | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 18, 2026 | RETEVMO | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 18, 2026 | OMNITROPE | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 17, 2026 | APO-DOXY; APO-DOXY-TABS | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 17, 2026 | NPLATE | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 17, 2026 | HERZUMA | Celltrion Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 17, 2026 | TEPADINA | Adienne Sa | Supplement to a New Drug Submission (SNDS) · Other |
| February 17, 2026 | OCREVUS | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 17, 2026 | MEN'S HAIR REGROWTH TREATMENT | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 17, 2026 | ODAN ITRACONAZOLE | Odan Laboratories Ltd. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 17, 2026 | OLANZAPINE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 17, 2026 | CYESTRA-35 | Knight Therapeutics Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 16, 2026 | PANZYGA | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| February 16, 2026 | TARO-SIMVASTATIN | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 16, 2026 | SANDOSTATIN; SANDOSTATIN LAR | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 16, 2026 | MEKINIST | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 16, 2026 | TAFINLAR | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 16, 2026 | CLADRIBINE INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 16, 2026 | JAMP TEMAZEPAM | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| February 14, 2026 | AURO-ATORVASTATIN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 13, 2026 | ADRUXE | Dr Reddy's Laboratories Ltd | New Drug Submission (NDS) · Other |
| February 13, 2026 | ADVIL FLU | Haleon Canada ULC | Supplement to a New Drug Submission (SNDS) · Other |
| February 13, 2026 | LUXTURNA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 13, 2026 | FLUOROURACIL INJECTION | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 13, 2026 | KALETRA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| February 13, 2026 | ZAMINE 21; ZAMINE 28 | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 13, 2026 | MINT-CANDESARTAN | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 13, 2026 | ODAN-BUPROPION XL | Odan Laboratories Ltd. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 13, 2026 | LEFLUNOMIDE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 12, 2026 | RYMTI | Lupin Pharma Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 12, 2026 | ZEPBOUND | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 12, 2026 | CAELYX | Baxter Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| February 12, 2026 | RIFAPENTINE TABLETS | Macleods Pharmaceuticals Limited | New Drug Submission (NDS) · New Active Substance (NAS) |
| February 12, 2026 | VELSIPITY | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 12, 2026 | ZORYVE | Arcutis Canada, Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 11, 2026 | ZEMAIRA | Csl Behring Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 11, 2026 | FLAGYL | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 11, 2026 | QUILLIVANT ER CHEWABLE TABLETS | Kye Pharmaceuticals Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 11, 2026 | CELLCEPT; CELLCEPT I.V. | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 11, 2026 | LORBRENA | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 11, 2026 | CHILDREN'S MOTRIN; CHILDREN'S MOTRIN CHEWABLE TABLETS; INFANTS' MOTRIN; JUNIOR STRENGTH MOTRIN CHEWABLE TABLETS | Kenvue Canada Inc. | New Drug Submission (NDS) · Admin |
| February 10, 2026 | EMEQUEL | Modern Veterinary Therapeutics Llc | Abbreviated New Drug Submission (ANDS) · Other |
| February 10, 2026 | UNITUXIN | United Therapeutics Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| February 10, 2026 | SPIKEVAX | Moderna Biopharma Canada Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| February 10, 2026 | CIBINQO | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 10, 2026 | VARIZIG | Ki Biopharma Llc | Supplement to a New Drug Submission (SNDS) · Other |
| February 10, 2026 | ZONOVATE | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 10, 2026 | TALZENNA | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 10, 2026 | APO-RAMIPRIL | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 10, 2026 | LONGAVO | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 10, 2026 | SILDENAFIL CITRATE | Jubilant Generics Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 10, 2026 | BIVALIRUDIN FOR INJECTION | Formative Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 10, 2026 | PREGABALIN ORAL SOLUTION | Orb Pharma- Division Of Odan Laboratories Ltd. | New Drug Submission (NDS) · Admin |
| February 10, 2026 | JAMP ENZALUTAMIDE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 10, 2026 | HUMALOG | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 9, 2026 | TARO-AMPHETAMINE XR | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 9, 2026 | SUGAMMADEX INJECTION | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 9, 2026 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| February 9, 2026 | METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION, USP | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| February 9, 2026 | GEMCITABINE INJECTION | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| February 9, 2026 | TEZSPIRE | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 9, 2026 | NAT-POMALIDOMIDE | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 9, 2026 | TERBINAFINE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 9, 2026 | SANDOZ LISDEXAMFETAMINE CAPSULES | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 9, 2026 | APO-OXCARBAZEPINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 9, 2026 | SUGAMMADEX INJECTION | Formative Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 9, 2026 | PMS-TOPIRAMATE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 9, 2026 | TEVA-LISDEXAMFETAMINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 6, 2026 | OPDIVO SC | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| February 6, 2026 | ENTYVIO | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| February 6, 2026 | LUNSUMIO | Hoffmann-La Roche Limited | New Drug Submission (NDS) · New Active Substance (NAS) |
| February 6, 2026 | TARO-PALBOCICLIB | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 6, 2026 | PANHEMATIN | Recordati Rare Diseases Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 6, 2026 | VIMIZIM | Biomarin International Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 6, 2026 | VINCRISTINE SULFATE INJECTION | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 6, 2026 | RETEVMO | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 6, 2026 | AG-AMOXICILLIN | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 6, 2026 | ACT METHYLPHENIDATE ER | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 6, 2026 | JAMP ACITRETIN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 5, 2026 | ACH-ATORVASTATIN CALCIUM | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 5, 2026 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| February 5, 2026 | AJOVY | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 5, 2026 | CRESTOR | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 5, 2026 | JAMP DILTIAZEM T | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 5, 2026 | TARO-SODIUM FUSIDATE | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 5, 2026 | RIVA-PRAVASTATIN | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 4, 2026 | XENPOZYME | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 4, 2026 | MINT-ZOPICLONE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 4, 2026 | TEVA-EMTRICITABINE/TENOFOVIR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 4, 2026 | AURO-CELECOXIB | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 4, 2026 | CYCLOBENZAPRINE | Sanis Health Inc. | New Drug Submission (NDS) · Admin |
| February 4, 2026 | NRA-VENLAFAXINE XR | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 4, 2026 | JAMP ENZALUTAMIDE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 4, 2026 | JAMP ENZALUTAMIDE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| February 3, 2026 | BRILINTA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 3, 2026 | HUMATE-P | Csl Behring Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 3, 2026 | APO-GABAPENTIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 3, 2026 | AG-DAPAGLIFLOZIN | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 3, 2026 | METFORMIN XR; TARO-METFORMIN XR | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| February 3, 2026 | AMB-SOTALOL | Ambicare Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 3, 2026 | PRO-LEVOFLOXACIN | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| February 3, 2026 | NEXIUM 24HR | Haleon Canada ULC | Supplement to a New Drug Submission (SNDS) · Other |
| February 3, 2026 | KEYTRUDA; KEYTRUDA SC | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 2, 2026 | ONCOTICE | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 2, 2026 | MEGESTROL | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 2, 2026 | NEUPRO | Ucb Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 2, 2026 | ONE-ALPHA | Cheplapharm Arzneimittel Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| February 2, 2026 | OTULFI; OTULFI I.V. | Fresenius Kabi Canada Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| February 2, 2026 | IRINOTECAN HYDROCHLORIDE INJECTION | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 2, 2026 | TRINIPATCH 0.2; TRINIPATCH 0.4; TRINIPATCH 0.6 | Knight Therapeutics Inc. | New Drug Submission (NDS) · Admin |
| February 2, 2026 | AZACITIDINE FOR INJECTION | Msn Labs Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 2, 2026 | NRA-ZOLMITRIPTAN | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 2, 2026 | PMS-NILOTINIB | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 2, 2026 | NRA-ONDANSETRON | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 2, 2026 | APO-SITAGLIPTIN/METFORMIN XR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 2, 2026 | DILTIAZEM T | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 2, 2026 | ADVIL BACK PAIN | Haleon Canada ULC | New Drug Submission (NDS) · Admin |
| January 30, 2026 | ATORVASTATIN | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 30, 2026 | MAR-ATORVASTATIN | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 30, 2026 | OVIMA 21; OVIMA 28 | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 30, 2026 | TEVA-RIVAROXABAN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 30, 2026 | ENFLONSIA | Merck Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| January 30, 2026 | APO-RIVAROXABAN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 30, 2026 | LIVMARLI | Mirum Pharmaceuticals, Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 30, 2026 | ZOLMITRIPTAN-ODT | Jubilant Generics Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 30, 2026 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Jubilant Generics Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 30, 2026 | APO-MIRABEGRON | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 30, 2026 | RECARBRIO | Merck Canada Inc | New Drug Submission (NDS) · Priority-NAS |
| January 30, 2026 | NRA-ENALAPRIL | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 30, 2026 | NRA-ANASTROZOLE | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 29, 2026 | BRENZYS | Samsung Bioepis Co., Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| January 29, 2026 | ALEMBIC-DEFERASIROX | Alembic Pharmaceuticals Limited | Abbreviated New Drug Submission (ANDS) · Other |
| January 29, 2026 | TEVA-SPIRONOLACTONE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 29, 2026 | HYRNUO | Bayer Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| January 29, 2026 | AURO-MIRABEGRON | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 29, 2026 | LAPELGA | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 29, 2026 | PAIN RELIEF GEL EXTRA STRENGTH | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 28, 2026 | FULVESTRANT INJECTION | Formative Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 28, 2026 | YORVIPATH | Pendopharm Division Of Pharmascience Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| January 28, 2026 | NRA-ONDANSETRON ODT | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 27, 2026 | SUGAMMADEX INJECTION | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 27, 2026 | FIBRYGA | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| January 27, 2026 | INFLUVAC | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| January 27, 2026 | SCEMBLIX | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 27, 2026 | OPDUALAG | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| January 27, 2026 | RIVA-LACOSAMIDE | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 27, 2026 | OLANZAPINE-ODT | Jubilant Generics Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 27, 2026 | DANTRIUM CAPSULES | Knight Therapeutics Inc. | New Drug Submission (NDS) · Admin |
| January 26, 2026 | TALZENNA | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| January 26, 2026 | XTANDI | Astellas Pharma Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 23, 2026 | AMLODIPINE | Jubilant Generics Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 23, 2026 | OMLYCLO | Celltrion Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 23, 2026 | CEFA-LAK | Boehringer Ingelheim Animal Health Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 22, 2026 | THYMOGLOBULIN | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 22, 2026 | TARO-FINGOLIMOD | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 22, 2026 | APO-WARFARIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 22, 2026 | APO-WARFARIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 22, 2026 | OLANZAPINE | Jubilant Generics Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 22, 2026 | PRO-ELETRIPTAN | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| January 22, 2026 | GAZYVA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 22, 2026 | ROZLYTREK | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 22, 2026 | TEVA-DASATINIB | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 22, 2026 | RIVA-GABAPENTIN | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 22, 2026 | SILENOR | Knight Therapeutics Inc. | New Drug Submission (NDS) · Admin |
| January 22, 2026 | IMFINZI | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Priority |
| January 21, 2026 | FLUGLUCOSCAN | Alberta Health Services | Supplement to a New Drug Submission (SNDS) · Other |
| January 21, 2026 | IDACIO | Fresenius Kabi Canada Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| January 21, 2026 | LEVETIRACETAM FOR INJECTION | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 21, 2026 | MYCOBUTIN | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| January 21, 2026 | APO-LEVOMILNACIPRAN | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 21, 2026 | VOXZOGO | Biomarin International Limited | New Drug Submission (NDS) · New Active Substance (NAS) |
| January 21, 2026 | TEVA-GLATIRAMER ACETATE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 21, 2026 | JAMP BRIMONIDINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 21, 2026 | AMIODARONE HYDROCHLORIDE FOR INJECTION | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 21, 2026 | APO-LATANOPROST | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 21, 2026 | RIVA-MONTELUKAST; RIVA-MONTELUKAST FC | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 21, 2026 | IRBESARTAN/HCTZ | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 21, 2026 | POTELIGEO | Kyowa Kirin, Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 21, 2026 | JAMP-CETIRIZINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 20, 2026 | LUNESTA | Knight Therapeutics Inc. | New Drug Submission (NDS) · Admin |
| January 20, 2026 | M-DONEPEZIL | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 20, 2026 | CANESORAL; CANESORAL COMBI 1 DAY | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 19, 2026 | OZEMPIC | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 19, 2026 | KERENDIA | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 19, 2026 | LUPIN-PROPRANOLOL LA | Lupin Pharma Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 19, 2026 | ZOLEDRONIC ACID INJECTION | Juno Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 19, 2026 | IBUPROFEN CAPLETS; IBUPROFEN EXTRA STRENGTH CAPLETS; IBUPROFEN TABLETS | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 16, 2026 | JAMP FENOFIBRATE E | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| January 16, 2026 | PMS-ATENOLOL | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 16, 2026 | PLAQUENIL | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 16, 2026 | AG-OLOPATADINE 0.2% | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 16, 2026 | TESTIM 1% | Knight Therapeutics Inc. | New Drug Submission (NDS) · Admin |
| January 16, 2026 | DANTRIUM INTRAVENOUS | Knight Therapeutics Inc. | New Drug Submission (NDS) · Admin |
| January 15, 2026 | ZIIHERA | Jazz Pharmaceuticals Ireland Limited | New Drug Submission (NDS) · New Active Substance (NAS) |
| January 15, 2026 | SANDOZ AMPHETAMINE XR | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| January 15, 2026 | RIVA-DAPAGLIFLOZIN | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 15, 2026 | GLEEVEC | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 15, 2026 | NRA-HYDROXYCHLOROQUINE | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 14, 2026 | CEQUA | Sun Pharmaceutical Industries Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 14, 2026 | IXCHIQ | Valneva Austria Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| January 14, 2026 | MRESVIA | Moderna Biopharma Canada Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| January 14, 2026 | JORNAY PM | Knight Therapeutics Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 13, 2026 | PMS-SACUBITRIL-VALSARTAN | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 13, 2026 | APO-RILUZOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 13, 2026 | APO-DOXY-TABS | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 13, 2026 | APO-CANAGLIFLOZIN | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 13, 2026 | AMB-CYPROTERONE ACETATE / ETHINYL ESTRADIOL | Ambicare Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 13, 2026 | BIO-SOLIFENACIN | Biomed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| January 13, 2026 | APO-FLECAINIDE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 13, 2026 | TEVA-VORICONAZOLE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 13, 2026 | SPC-MINOCYCLINE | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 13, 2026 | ARIPIPRAZOLE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 12, 2026 | IMULDOSA; IMULDOSA IV | Accord Healthcare Inc | New Drug Submission (NDS) · Other |
| January 12, 2026 | CETIRIZINE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 12, 2026 | EBGLYSS | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 12, 2026 | RYBREVANT | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 10, 2026 | LAMOTRIGINE-100; LAMOTRIGINE-150; LAMOTRIGINE-25 | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 9, 2026 | APO-PRUCALOPRIDE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 9, 2026 | LUPIN-CELECOXIB | Lupin Pharma Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 9, 2026 | TAKHZYRO | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| January 9, 2026 | HALOPERIDOL DECANOATE LA INJECTION | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| January 9, 2026 | ERIBULIN MESYLATE INJECTION | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 9, 2026 | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | Fresenius Kabi Canada Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| January 9, 2026 | TEVA-CETIRIZINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 9, 2026 | TRIKAFTA | Vertex Pharmaceuticals (Canada) Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| January 9, 2026 | PRIMAQUINE | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 9, 2026 | APO-NAPROXEN / ESOMEPRAZOLE | Apotex Inc. | New Drug Submission (NDS) · Admin |
| January 9, 2026 | AURO-METHOTREXATE TABLETS | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 9, 2026 | JAMP CLONIDINE TABLETS | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| January 9, 2026 | VORICONAZOLE FOR INJECTION | Eugia Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 9, 2026 | NYDA | G. Pohl-Boskamp GmbH & Co. KG | Supplement to a New Drug Submission (SNDS) · Other |
| January 8, 2026 | POTELIGEO | Kyowa Kirin, Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 8, 2026 | ESTRING | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| January 8, 2026 | CARVEDILOL | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 8, 2026 | MYFORTIC | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 7, 2026 | PRO-GABAPENTIN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 7, 2026 | CABENUVA | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| January 7, 2026 | APRETUDE | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| January 7, 2026 | AURO-FINASTERIDE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 7, 2026 | APO-LABETALOL | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 7, 2026 | GENTAMICIN INJECTION USP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 7, 2026 | APO-METHADONE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 7, 2026 | PROVERA | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| January 6, 2026 | DYRUPEG | Curateq Biologics Private Limited | New Drug Submission (NDS) · Other |
| January 6, 2026 | TREMFYA ONE-PRESS | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 6, 2026 | CLARUS | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 6, 2026 | MINT-HYDRALAZINE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 6, 2026 | ALTUVIIIO | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 5, 2026 | BEPREVE | Bausch & Lomb Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 5, 2026 | PROSTIN VR STERILE SOLUTION | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| January 5, 2026 | TRIAZOLAM | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 5, 2026 | AURO-LORAZEPAM | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 2, 2026 | REDEMPLO | Arrowhead Pharmaceuticals, Inc. | New Drug Submission (NDS) · Priority-NAS |
| January 2, 2026 | AURO-CANAGLIFLOZIN | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 2, 2026 | SANDOZ CANAGLIFLOZIN | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 2, 2026 | SANDOZ CANAGLIFLOZIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 2, 2026 | SANDOZ CANAGLIFLOZIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 2, 2026 | AG-CANAGLIFLOZIN | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 2, 2026 | AURO-CANAGLIFLOZIN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 2, 2026 | SANDOZ CANAGLIFLOZIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 2, 2026 | AG-CANAGLIFLOZIN | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 2, 2026 | TEVA-GABAPENTIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 2, 2026 | AURO-CANAGLIFLOZIN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 2, 2026 | CETIRIZINE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 2, 2026 | NB-ALENDRONATE-FC | NB Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 2, 2026 | PMS-METRONIDAZOLE GEL | Pharmascience Inc. | New Drug Submission (NDS) · Admin |
| January 2, 2026 | AURO-PAZOPANIB | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 2, 2026 | MYLAN-AMLODIPINE/ATORVASTATIN | Mylan Pharmaceuticals Ulc | Supplement to a New Drug Submission (SNDS) · Admin |
| January 2, 2026 | PRAVASTATIN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 2, 2026 | NRA-APIXABAN | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 2, 2026 | JAMP CANAGLIFLOZIN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 2, 2026 | JAMP CANAGLIFLOZIN | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| January 2, 2026 | DONEPEZIL | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |